Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949138-16143257	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	10.4	11.6	0.3	4.0	0.2	3.6	8.6	0.3	0.7	10.4	4.1	16.1	1.1	11.0	0.1	22.8	7.0	3.1	11.2	0.3	0.5	8.0	2.3	15.5	4.4	1.1	0.8	8.9	8.9	3.6	7.2	2.0	0.7	15.2	0.7	0.4	9.2	0.9	21.2	9.7	12.4	6.3	0.5	15.7	15.0	13.1	0.6	4.3	21.0	0.1	1.1	15.4	12.8	0.9	4.3	43.7	0.3	11.7	3.2	4.5	0.5	15.4	19.0	13.1	13.8	6.7	34.8	7.0	79.6	29.6	11.0	12.1	3.4	12.4	4.6	22.2	4.4	16.4	22.0	16.3	25.1	5.9	39.5	15.0	9.0	1.1	2.3	3.8	10.2	28.6	17.8	6.8	0.5	5.4	12.0	0.9	3.5	1.8	8.2	41.9	7.8	5.3	0.7	15.2	6.4	11.8	18.9	17.8	3.6	11.9	6.2	0.8	3.5	0.4	2.0	11.4	11.9	13.5	7.4	3.3	6.6	0.6	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.5	1.1	0.8	0.7	0.5	0.6	0.9	8.6	25.6	5.6	10.7	13.1	8.8	8.5	18.2	9.6	3.1	4.4	3.7	6.0	4.3	14.4	5.5	22.9	0.9	9.8	2.7	3.9	9.1	11.0	15.7	12.9	8.6	18.6	16.0	26.6	6.2	3.2	12.3	49.5	17.8	22.1	16.8	8.6	0.4	8.5	5.0	38.5	6.6	14.2	21.4	9.1	14.3	7.5	12.2	3.6	11.2	10.5	1.2	5.2	12.1	15.9	11.2	4.5	6.8	15.7	18.7	0.5	1.1	9.9	8.8	0.0	6.4	5.1	4.9	6.6	18.1	5.1	0.5	17.4	37.1	3.7	11.6
ACTG1	"ACTG, DFNA20, DFNA26"	ENSG00000184009	"Actin gamma 1"	P63261	17	81509413-81523847	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 9107.1;Exocrine glandular cells: 8305.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041264, HPA041271"	Approved					NA	NA		4900000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (3.95e-2)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-3)"	1548.5	950.4	523.3	1325.4	549.3	1130.2	1158.2	582.8	628.6	1634.2	506.2	1258.5	994.5	1629.9	558.1	2422.2	1315.8	1179.5	666.3	548.5	677.3	905.8	762.8	1516.1	1696.9	652.8	592.5	2046.6	1693.4	608.2	824.5	922.4	629.8	723.8	662.3	293.9	1291.3	643.0	358.4	1455.8	1026.3	739.2	589.8	1034.8	1385.5	438.5	611.8	1347.8	1252.2	270.9	1292.7	1540.3	1571.3	709.7	3652.9	4010.4	4601.5	2275.7	813.0	2758.2	1601.3	4193.6	3154.7	3546.5	2675.5	3699.5	1690.3	2114.0	2566.1	4263.6	2867.3	2049.5	1722.7	3395.6	1727.7	3745.8	2549.8	1724.3	1784.6	3515.1	2165.8	1909.2	2003.4	3599.7	1366.0	3586.4	938.0	4516.4	5237.2	1343.4	331.2	2723.2	3288.0	2677.4	6305.5	2235.8	1970.8	2272.7	2122.3	3520.6	1537.3	1716.3	3385.4	2838.3	1234.4	1284.1	4804.4	969.0	5127.0	1530.7	2192.3	1908.9	5402.3	4755.5	1993.3	2802.6	7012.2	908.3	791.7	1505.4	3808.4	1910.5	2940.1	4240.1	1897.3	3013.3	2108.9	2333.9	2026.4	1297.8	1892.2	2024.3	3012.5	939.2	1391.8	1827.7	1532.7	1355.2	2939.2	1616.5	2980.5	5301.8	523.3	549.3	582.8	628.6	548.5	677.3	652.8	592.5	629.8	589.8	611.8	709.7	1602.0	974.4	558.2	107.1	1285.4	5276.1	9107.1	3827.4	2541.1	493.3	1477.5	1943.4	233.6	825.0	1924.3	1140.3	244.0	2002.6	1886.0	2460.0	1058.5	4368.6	293.0	1028.0	1501.0	1664.2	1914.5	567.0	59.0	8305.0	4361.7	1595.3	2440.4	1433.3	588.7	3067.7	1031.6	517.1	3219.5	267.5	65.7	2206.9	1957.2	1426.0	1807.7	258.5	1718.6	1840.3	1398.1	70.3	4004.3	3402.9	1971.2	78.4	111.9	7194.7	2426.5	1363.9	1369.6	3987.9	1673.2	566.6	950.0	571.1	1360.8	873.0	2277.1	756.5	995.7	3085.9	5371.9	2827.2	1823.7	2394.4	2187.5	6279.2
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.7;liver: 19.2;retina: 53.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 521.3;Excitatory neurons: 147.2;Inhibitory neurons: 117.9;Rod photoreceptor cells: 174.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;SH-SY5Y: 25.5;SK-MEL-30: 30.1;WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	1.9	1.8	13.7	0.3	22.4	0.0	4.7	15.4	33.7	5.3	0.0	0.4	0.2	1.8	0.5	0.6	2.0	0.6	2.9	31.9	0.0	1.9	19.2	0.6	0.4	1.2	0.9	0.9	3.3	1.9	2.6	0.4	1.1	2.8	0.4	53.0	0.3	1.2	7.7	0.4	0.3	0.9	0.0	1.7	1.1	2.8	4.0	0.3	2.4	8.5	0.3	0.8	1.3	24.5	0.8	5.9	2.1	3.2	4.1	0.1	4.0	0.2	0.0	0.8	0.3	0.6	0.0	0.0	0.2	0.2	5.8	1.9	3.8	0.3	0.1	10.7	2.7	0.0	0.0	0.6	0.0	0.2	0.1	4.9	2.8	0.5	22.2	0.0	0.1	8.6	0.3	7.0	0.3	7.1	0.0	0.0	8.3	5.1	0.0	0.0	0.0	11.7	0.0	5.7	13.4	25.5	2.1	0.0	30.1	3.1	2.0	3.5	0.0	0.6	4.2	0.5	3.6	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	22.4	15.4	33.7	31.9	0.0	1.2	0.9	1.1	0.0	4.0	24.5	3.5	0.0	0.0	30.7	0.3	0.3	0.6	0.0	0.0	43.8	10.6	5.7	11.4	2.8	0.0	0.0	521.3	0.1	0.3	0.5	1.9	0.0	2.9	1.0	23.1	10.8	31.2	0.0	147.2	0.9	0.2	4.2	0.0	0.7	0.0	0.2	15.7	52.3	0.3	42.1	117.9	1.0	2.0	3.2	0.4	0.7	1.8	0.2	3.6	17.8	0.0	13.8	0.0	63.3	4.0	0.5	0.1	7.5	0.1	2.6	0.0	0.4	0.0	174.4	0.0	2.3	8.8	0.5	6.8	0.1	0.1	0.0	0.6	0.6	0.6	0.3
AIFM1	"AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130124666-130165879	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Dwarfism, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 165.4;Proximal tubular cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced		Supported	Mitochondria		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003764: AB_289587, HPA030611: AB_2673549"	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favorable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	21.0	65.2	10.5	17.6	11.2	11.8	17.8	11.9	12.8	15.7	24.7	34.3	52.9	15.3	8.9	20.8	22.1	10.1	107.7	10.9	11.6	97.3	110.6	13.9	16.2	11.3	11.0	11.9	27.8	29.7	16.2	10.3	11.4	14.8	15.9	8.5	18.6	7.6	68.9	15.2	29.9	10.1	11.2	20.3	41.2	30.3	12.1	18.5	14.7	25.2	11.0	18.4	13.4	11.6	52.8	95.4	22.6	85.2	24.1	14.6	50.0	28.6	19.0	33.5	25.2	55.8	36.4	105.0	113.3	17.5	39.3	47.2	61.3	33.3	12.7	48.2	73.4	61.6	59.1	68.9	34.0	51.5	63.5	26.1	21.7	34.5	22.0	12.1	27.2	83.4	62.6	50.7	13.1	96.7	57.6	74.5	24.4	53.6	65.1	55.6	31.7	132.7	60.8	36.6	46.0	28.2	35.5	68.0	67.5	13.2	46.0	40.8	31.7	20.5	20.4	63.9	58.7	24.2	45.0	47.5	25.3	86.4	33.4	4.1	21.0	14.1	11.8	26.6	13.1	14.6	12.8	14.6	31.7	10.3	12.7	12.6	2.4	20.7	24.8	14.7	17.9	12.4	10.5	11.2	11.9	12.8	10.9	11.6	11.3	11.0	11.4	11.2	12.1	11.6	12.6	16.0	20.1	17.0	17.1	8.7	8.2	25.0	9.1	19.3	13.0	8.3	165.4	22.8	21.2	40.5	22.9	58.0	14.2	31.6	92.0	24.9	1.8	36.7	17.3	11.5	9.6	26.3	10.8	20.5	29.0	16.4	27.0	50.4	10.8	33.1	14.3	92.3	38.0	15.2	12.1	24.0	34.6	14.4	7.4	4.9	17.4	16.8	10.6	8.4	16.6	17.2	20.6	8.0	19.6	18.0	18.9	17.3	19.2	7.9	45.6	326.1	21.3	48.1	6.6	11.3	39.3	10.2	32.0	17.1	6.8	39.7	15.8	45.9	37.2	9.8
AP000812.4		ENSG00000284922	"Leucine rich transmembrane and O-methyltransferase domain containing"	Q8WZ04	11	72080331-72110782	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Hearing, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 14.1;testis: 9.5"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.9;HBEC3-KT: 2.9;MCF7: 3.0"									HPA039949	Approved		Uncertain	Microtubules		NA	NA					"Cluster 40: Non-specific - Basic cellular processes"		Microtubules		"HPA039949: AB_10960708"																		0.1	0.0	0.4	0.0	0.5	0.0	0.2	0.6	1.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	14.1	0.0	0.0	0.3	0.6	0.4	0.2	0.6	0.0	0.4	0.4	0.2	0.0	0.5		0.0	0.4	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.2	0.2	0.3	0.2	0.0	9.5	0.4	0.0	0.1	0.0	0.0	0.1		0.6	0.2	0.1	0.0	0.2	0.7	0.2	0.1	0.4	0.5	0.3	1.2	0.2	0.2	0.0	0.1	2.9	0.5	0.6	0.4	2.9	0.3	1.2	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.8	0.0	1.3	0.4	0.1	0.1	0.6	0.0	0.0	0.4	3.0	0.0	0.0	0.1	1.0	0.0	0.6	0.5	0.2	0.9	0.5	0.3	0.1	0.4	0.3	0.0	0.0	0.9	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	1.8	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.4;ovary: 78.7;skeletal muscle: 26.7"	"Group enriched"	"Detected in some"	5	"Enteroendocrine cells: 83.7;Inhibitory neurons: 53.2;Leydig cells: 131.7;Peritubular cells: 70.0;Theca cells: 66.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.9;PC-3: 3.9;THP-1: 1.7;U-266/70: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"				"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.0	0.1	7.6	0.0	10.1	0.0	0.3	0.0	17.4	0.0	0.0	0.9	3.5	0.0	0.1	0.1	1.1	0.0	0.0	10.1	6.0	0.1	0.0	0.4	0.0	0.0	0.0	78.7	1.4	1.8	0.3	0.0	0.1	0.7	0.9	0.0	0.2	0.0	26.7	0.0	0.7	0.0	0.0	0.2	5.5	7.2	0.4	0.0	0.2	1.9	0.4	0.0	0.2	8.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	3.9	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.1	0.0	0.0	8.3	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	10.1	0.0	17.4	10.1	6.0	0.0	0.0	0.1	0.0	0.4	8.0	0.0	0.0	0.0	14.0	0.3	0.0	2.5	0.5	0.0	0.0	0.3	0.0	0.5	0.0	2.2	0.0	0.0	0.2	0.1	1.9	0.0	0.0	1.2	0.0	0.0	0.1	83.7	0.0	0.2	0.0	2.4	4.7	4.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	53.2	3.6	4.1	0.0	0.0	3.6	131.7	0.2	0.0	3.7	0.0	0.0	0.0	3.5	0.6	0.3	0.8	70.0	0.9	1.3	0.1	0.1	11.3	0.0	0.0	1.5	0.3	0.5	0.3	0.0	0.0	0.1	0.3	66.8	1.9	1.6
BDP1	"HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR"	ENSG00000145734	"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB"	A6H8Y1	5	71455651-71567820	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064166, HPA077984"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA064166: , HPA077984: "	"unprognostic (4.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.86e-2)"	2.5	2.7	0.5	1.3	0.6	0.9	3.4	0.8	1.7	1.8	0.2	0.9	0.0	1.2	0.0	0.8	1.2	2.0	0.7	0.5	0.5	2.7	1.6	1.4	1.2	0.5	0.5	1.8	4.0	0.3	0.3	1.4	0.5	1.5	2.3	5.8	0.8	1.9	2.2	1.9	0.8	2.0	0.5	0.7	1.0	0.9	0.4	2.3	2.8	3.5	1.6	0.9	0.6	0.9	1.3	2.1	10.1	3.1	1.6	5.0	7.7	0.2	0.1	2.4	0.0	0.7	1.0	0.5	9.4	4.0	11.0	0.0	3.2	0.2	11.0	0.0	0.0	1.6	7.0	3.1	4.2	4.4	0.4	0.0	0.1	0.9	5.9	5.4	7.9	0.0	12.7	0.7	5.0	3.9	0.0	1.2	0.0	1.0	7.7	10.5	1.3	7.9	4.4	6.6	1.2	7.3	0.2	2.1	6.4	7.2	0.0	0.0	16.1	5.6	0.9	3.6	0.5	3.4	8.5	0.1	0.0	3.8	8.6	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.6	0.8	1.7	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.9	69.5	60.9	96.2	52.5	79.7	44.5	63.7	26.9	55.8	78.2	57.9	55.8	110.7	38.6	57.3	35.0	102.2	37.9	101.1	38.7	1.9	48.1	37.8	88.7	109.5	71.7	58.6	59.7	116.7	36.3	50.2	57.0	57.1	127.3	58.2	66.0	28.9	32.0	31.7	94.2	96.4	39.3	24.4	27.7	36.9	21.1	58.7	53.3	28.4	57.1	62.3	41.7	76.2	57.3	86.8	52.2	26.0	54.5	72.3	57.9	18.5	10.9	39.9	125.1	52.6	104.3	74.0	85.8	60.4	60.0	43.3	48.2	86.3	69.0	50.0	64.5
CABP2	DFNB93	ENSG00000167791	"Calcium binding protein 2"	Q9NPB3	11	67518912-67524517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"retina: 7.3"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 100.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 9.3"	"Not detected"	"Not detected"									NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 56: Bipolar cells - Visual perception"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.2	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC50	"C3orf6, DFNA44, Ymer"	ENSG00000152492	"Coiled-coil domain containing 50"	Q8IVM0	3	191329085-191398659	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 363.7;Oligodendrocyte precursor cells: 365.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 630.7"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 630.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001336	Approved		Supported	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA001336: AB_1078421"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.73e-2)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.03e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.19e-1)"	63.2	28.3	19.6	34.3	20.7	10.3	30.6	21.5	19.1	24.1	18.8	26.9	24.2	33.0	24.8	27.9	24.3	34.8	39.7	17.6	23.3	32.4	56.5	31.6	42.2	24.1	22.0	46.2	35.1	27.6	13.5	34.9	24.1	26.2	25.4	11.8	23.7	33.3	19.0	18.4	25.8	48.1	23.2	45.0	24.3	29.6	21.3	17.7	27.4	26.1	41.0	36.7	18.6	24.7	74.9	24.5	93.6	24.7	82.3	72.1	32.3	135.4	135.2	95.4	95.0	52.6	28.9	14.6	163.0	76.8	70.6	83.6	75.6	60.5	141.9	109.0	37.8	10.0	31.7	60.3	120.8	36.8	37.8	58.2	79.3	75.6	169.7	82.2	148.7	0.0	33.9	77.3	85.4	26.0	0.2	23.1	33.2	7.6	103.0	56.3	51.9	73.1	104.3	31.9	21.8	33.2	48.2	51.6	95.8	67.3	35.6	32.9	153.3	93.4	78.4	68.4	176.3	118.6	54.9	0.9	50.5	0.1	76.9	0.1	22.1	2.1	5.9	20.8	2.4	128.5	6.1	3.9	44.3	76.5	1.3	1.5	2.2	24.0	12.1	630.7	22.1	18.0	19.6	20.7	21.5	19.1	17.6	23.3	24.1	22.0	24.1	23.2	21.3	24.7	143.5	25.6	54.5	40.5	134.5	46.9	52.5	30.7	30.7	27.2	32.5	37.5	48.4	58.6	34.7	51.5	27.1	28.1	363.7	44.1	31.3	120.4	183.0	97.3	58.1	134.0	22.8	11.2	15.8	78.5	36.3	66.6	41.8	79.0	2.5	58.5	175.6	79.5	84.4	25.2	41.3	33.8	38.7	59.4	78.3	92.1	69.3	61.4	53.4	98.4	101.4	32.1	5.2	365.4	28.9	174.7	33.9	75.6	102.7	69.8	37.6	71.8	26.3	14.4	59.2	74.1	65.7	73.2	26.6	24.0	32.5	33.5	22.4	49.5	33.7	62.4
CD164	"DFNA66, MGC-24, MUC-24"	ENSG00000135535	"CD164 molecule"	Q04900	6	109366514-109382467	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010636	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA010636: AB_1078447"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.51e-1)"	260.9	123.6	43.6	119.1	53.6	213.9	211.2	57.4	69.5	151.0	68.9	264.8	252.0	117.0	161.9	95.0	124.8	159.3	91.8	40.6	57.7	298.1	256.8	121.9	137.8	65.3	56.1	126.4	124.1	219.2	89.5	190.1	64.1	146.1	270.5	36.4	303.8	112.7	96.0	89.2	277.6	116.1	52.3	121.0	272.8	113.6	50.7	132.0	360.4	91.7	122.9	154.2	76.0	70.7	130.0	73.0	34.6	242.9	503.0	496.6	235.7	230.8	304.0	213.7	308.0	148.1	194.9	105.7	218.0	261.5	198.0	125.4	136.9	152.7	315.4	220.1	144.5	177.8	72.0	173.9	294.9	209.5	399.0	384.6	279.7	211.3	186.5	270.3	196.9	86.9	178.9	279.9	287.8	141.1	191.5	251.2	52.9	273.1	119.6	126.3	109.0	135.1	292.2	180.5	40.2	80.9	144.6	184.0	348.6	168.0	167.7	265.0	205.6	138.8	99.1	199.5	188.6	96.3	147.4	121.2	244.0	242.8	147.2	349.0	192.3	167.0	166.8	198.6	175.0	126.2	135.2	155.1	189.7	111.0	138.0	150.1	128.5	255.2	197.5	214.1	192.9	413.8	43.6	53.6	57.4	69.5	40.6	57.7	65.3	56.1	64.1	52.3	50.7	70.7	76.5	163.5	78.9	22.5	168.1	200.1	180.2	149.6	128.7	33.8	251.1	123.3	70.9	174.5	153.5	281.4	25.0	244.9	372.7	600.0	93.9	178.8	103.8	111.9	109.2	89.2	166.5	92.8	22.1	136.8	407.2	176.3	175.8	151.2	128.6	76.7	98.2	177.4	311.9	33.7	16.4	427.3	215.7	360.4	223.9	97.3	158.8	237.3	247.3	38.4	147.1	113.3	266.8	15.6	83.1	177.6	430.0	182.1	173.6	230.3	425.5	348.0	351.2	44.4	124.9	110.0	138.1	160.5	184.4	143.0	231.0	674.5	165.9	87.7	285.0	334.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDH23	"CDHR23, DFNB12, USH1D"	ENSG00000107736	"Cadherin related 23"	Q9H251	10	71396920-71815947	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.6;ovary: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.4;Late spermatids: 67.7;Microglial cells: 33.7;Muller glia cells: 90.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 26.8;non-classical monocyte: 38.1;plasmacytoid DC: 9.5"	"Lineage enhanced"	"Detected in many"		"monocytes: 38.1"	"Group enriched"	"Detected in some"	4	"RT4: 13.4;SCLC-21H: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017232	Approved					NA	NA		950000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA017232: AB_1845903"	"unprognostic (6.76e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.40e-4)"	11.3	3.3	9.6	2.1	11.6	2.2	6.2	10.6	7.9	3.3	10.2	1.7	1.1	4.9	1.6	1.8	8.9	2.2	5.4	6.3	16.2	0.9	14.4	7.8	1.7	35.6	18.5	35.3	8.4	9.9	1.2	0.5	34.7	3.7	1.2	14.4	1.2	0.7	2.7	1.6	2.3	2.1	8.6	7.0	1.7	11.0	23.6	5.3	1.8	2.5	1.4	4.2	2.6	8.8	0.0	0.7	0.8	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.9	0.4	1.3	0.0	0.0	0.1	1.2	1.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.1	1.5	0.4	0.0	1.1	0.0	0.1	0.0	13.4	5.3	1.1	0.8	0.2	0.1	1.1	0.1	2.2	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.2	1.5	1.0	0.0	0.0	6.0	5.1	0.1	26.8	0.4	0.0	0.2	0.1	4.9	0.0	0.2	0.6	6.1	0.0	38.1	9.5	0.0	2.9	9.6	11.6	10.6	7.9	6.3	16.2	35.6	18.5	34.7	8.6	23.6	8.8	8.2	0.0	0.6	9.4	1.1	0.8	4.1	0.3	0.6	1.9	0.2	1.1	4.7	0.0	1.0	1.8	0.0	1.5	11.5	0.9	0.0	0.4	78.4	1.9	0.7	10.0	7.2	0.0	1.1	0.4	4.4	3.4	1.1	0.3	0.0	0.4	7.9	20.4	2.2	0.0	2.7	1.1	0.0	12.2	11.6	67.7	2.5	15.0	7.2	33.7	10.6	90.7	3.1	1.5	8.5	0.2	7.5	0.7	0.4	2.6	1.6	0.8	0.7	4.2	6.6	5.1	1.7	3.4	1.0	0.0	1.1	0.3	1.0	0.2	0.7	3.6
CEACAM16	DFNA4B	ENSG00000213892	"CEA cell adhesion molecule 16, tectorial membrane component"	Q2WEN9	19	44699151-44710718	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"pancreas: 2.0"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 7.7;Skeletal myocytes: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045075	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA045075: AB_10959617"	"unprognostic (1.27e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.59e-2)"		"unprognostic (7.81e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.05e-1)"		"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"		"unprognostic (7.94e-2)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	20.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0
CIB2	"DFNB48, KIP2, USH1J"	ENSG00000136425	"Calcium and integrin binding family member 2"	O75838	15	78104606-78131535	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 47.7;lymphoid tissue: 47.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 73.1;Late spermatids: 269.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in single"	48	"dendritic cells: 18.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.0;GAMG: 39.0;HAP1: 38.6;SCLC-21H: 38.8;SH-SY5Y: 40.1;SuSa: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036697	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036697: AB_10672475"	"unprognostic (5.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.73e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.18e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.64e-3)"	7.0	12.1	16.7	3.1	16.9	1.6	4.8	15.9	22.9	13.1	13.8	9.6	18.7	9.1	3.1	4.0	5.7	2.8	47.7	18.1	17.4	9.1	1.2	3.0	3.5	20.1	18.3	7.3	5.9	13.4	10.4	3.7	20.1	10.4	7.1	5.0	8.1	8.7	11.4	6.8	24.6	6.6	17.5	3.0	3.9	23.3	16.9	47.8	4.0	1.9	6.5	8.6	7.8	16.2	3.5	8.6	24.2	44.0	1.1	1.4	18.1	2.4	0.9	2.0	4.2	0.0	9.6	0.4	4.8	11.3	39.0	1.9	38.6	7.7	0.6	21.7	26.8	2.6	1.6	1.4	4.3	0.0	3.4	2.1	3.2	3.5	2.0	5.0	4.2	13.0	9.1	0.2	3.7	0.7	1.1	0.4	31.1	1.2	0.3	16.9	0.1	1.0	2.8	0.7	38.8	40.1	5.9	3.1	3.5	49.2	0.6	2.6	0.3	0.1	20.3	2.2	0.3	0.4	0.4	6.7	1.0	0.1	5.4	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	18.7	0.0	0.2	16.7	16.9	15.9	22.9	18.1	17.4	20.1	18.3	20.1	17.5	16.9	16.2	11.0	0.0	0.0	1.6	3.6	5.5	26.6	2.3	1.8	2.9	3.4	12.6	11.4	1.5	0.5	1.8	6.2	19.4	17.3	14.9	9.8	3.0	73.1	1.6	8.1	3.0	3.0	3.0	1.6	1.1	15.5	9.5	2.0	1.5	0.0	10.7	2.5	0.4	2.8	5.0	3.9	25.1	2.0	0.6	1.4	269.9	3.4	2.3	7.2	1.0	0.1	18.1	1.0	2.5	0.4	1.5	16.2	2.6	1.7	12.3	35.9	10.6	0.2	2.2	6.6	11.5	4.9	10.0	17.5	0.4	3.1	9.3	2.5	18.0	11.1	11.5
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"kidney: 13.8;liver: 39.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Distal tubular cells: 19.6;Ductal cells: 11.8;Exocrine glandular cells: 8.2;Hepatocytes: 22.2;Pancreatic endocrine cells: 21.3"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 7.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"HDLM-2: 224.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054707			Uncertain	Vesicles		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA054707: "	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.87e-1)"	"unprognostic (7.44e-4)"	"unprognostic (2.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.71e-2)"	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.3	0.1	0.1	0.0	13.8	39.5	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.2	0.1	0.0	0.1	0.3	0.2	0.0	0.4	0.4	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	224.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.7	2.1	0.1	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	2.5	15.8	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.1	7.4	4.2	0.1	0.7	0.4	6.7	15.7	0.0	1.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.4	1.0	0.6	0.0	0.0	0.8	0.4	0.7	7.2	0.1	1.8	0.0	0.1	0.0	0.7	19.6	11.8	0.6	0.3	0.2	3.6	0.0	0.0	0.6	8.2	1.3	0.1	0.0	3.4	0.0	0.0	0.4	22.2	0.1	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.2	3.6	0.0	0.6	0.0	0.0	1.5	1.0	21.3	0.0	0.4	6.9	0.6	0.0	0.7	0.0	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.3	0.8	1.4	0.0	0.3	2.3
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	18.9	1.5	3.2	4.3	4.4	0.2	6.5	1.5	2.9	19.0	0.5	28.6	20.9	2.1	0.9	2.9	4.5	3.0	102.7	2.1	5.0	54.7	0.3	70.8	1.7	2.1	3.8	0.5	1.1	1.7	3.0	16.5	2.2	2.6	25.8	16.9	2.7	1.4	289.7	1.2	36.6	2.3	1.8	44.5	1.6	1.4	5.5	1.0	7.3	98.3	1.9	2.0	2.6	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.2	4.4	1.5	2.9	2.1	5.0	2.1	3.8	2.2	1.8	5.5	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Deafness, Disease variant, Dwarfism, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pituitary gland: 23.5;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.5;Early spermatids: 10.8;Muller glia cells: 5.2;Oligodendrocytes: 6.7"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		2100000		"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.0	0.3	0.3	0.0	0.6	0.0	0.9	0.5	0.6	1.6	0.0	0.7	0.2	1.2	0.2	0.5	0.9	0.1	1.8	0.3	0.3	1.3	0.8	1.0	0.0	0.5	0.4	1.1	0.6	0.1	23.5	0.0	0.5	1.3	0.0	0.1	0.8	0.1	1.3	0.6	0.7	0.1	0.5	1.2	0.7	8.1	0.5	0.3	3.5	0.7	0.0	0.6	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	0.3	0.3	0.5	0.4	0.5	0.5	0.5	0.8	2.6	0.0	0.0	8.5	0.1	1.5	0.2	0.1	1.8	2.8	1.2	1.8	2.3	0.0	0.1	0.0	4.2	0.0	0.6	0.3	0.0	0.1	10.8	0.2	0.6	1.5	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.5	0.0	0.6	4.6	0.2	0.2	0.0	3.7	0.1	0.0	0.6	0.4	1.9	0.0	0.3	1.8	1.0	0.0	5.2	0.0	3.5	6.7	0.1	0.6	0.4	0.8	0.2	0.0	0.1	0.0	1.1	0.0	0.7	1.8	0.9	2.1	0.7	1.1	0.0	0.4	0.2	0.5	0.1
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 32.6;urinary bladder: 40.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 24.5;Basal respiratory cells: 16.0;Cardiomyocytes: 13.1;Prostatic glandular cells: 12.1;Urothelial cells: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.0;HeLa: 40.1;HHSteC: 59.2;hTERT-HME1: 44.1;HUVEC TERT2: 41.7;TIME: 94.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"		"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	3.0	0.5	0.3	0.4	0.3	0.0	2.0	0.2	0.2	12.6	1.3	1.9	1.4	32.6	17.0	5.5	14.9	13.3	5.4	0.3	0.7	4.2	0.1	1.0	0.1	0.9	1.7	9.3	0.1	5.5	7.2	3.2	1.0	12.5	2.1	1.2	1.4	21.5	1.4	6.5	1.5	24.5	0.4	1.4	13.3	1.2	0.3	0.9	0.7	1.2	0.1	40.7	9.2	0.6	0.1	31.1	9.9	0.0	24.2	1.7	0.0	0.0	1.8	0.3	0.2	17.9	0.0	0.0	0.0	0.0	3.9	5.8	10.3	46.0	0.8	0.4	8.8	0.8	40.1	0.3	59.2	0.0	0.0	2.6	27.8	6.5	44.1	0.1	41.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.0	0.0	3.8	0.0	0.0	0.0	1.9	3.4	0.0	0.0	2.4	0.0	0.0	18.2	0.9	0.0	94.2	0.0	0.1	5.5	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.7	0.9	1.7	1.0	0.4	0.3	0.6	0.1	0.0	0.0	6.2	0.0	6.4	24.5	16.0	3.4	0.2	2.3	6.1	13.1	0.0	2.6	1.8	0.0	0.1	0.0	0.0	1.9	0.0	2.1	0.7	6.0	0.4	0.0	0.0	0.4	0.0	0.0	6.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	2.0	0.0	0.3	0.3	4.1	0.0	0.0	8.4	0.0	5.5	0.0	0.0	0.6	0.1	0.0	9.1	0.0	12.1	0.0	0.0	2.2	0.4	0.0	0.4	7.2	0.2	0.2	0.1	3.7	0.0	0.1	0.8	0.0	15.2
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.7;heart muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 82.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 82.0"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 100.3"	"Group enriched"	"Detected in all"	11	"amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.9	0.8	37.4	0.9	78.7	1.0	2.7	40.6	62.2	3.7	13.6	6.9	1.6	1.0	0.2	7.6	1.1	7.0	175.3	54.0	31.6	64.4	14.2	8.5	1.1	13.9	19.8	0.3	1.8	8.9	55.6	0.4	15.6	35.4	8.4	54.7	20.6	0.2	13.4	4.1	2.6	0.3	14.1	0.3	1.3	5.1	20.5	0.3	0.4	0.9	3.8	21.8	3.6	31.3	0.2	4.0	0.0	0.0	0.2	0.4	0.7	0.0	2.1	0.1	0.2	0.2	0.2	0.3	1.0	0.0	1.8	0.6	5.4	0.0	0.0	0.0	0.8	23.2	0.1	2.3	0.0	0.1	2.2	0.8	0.0	0.8	1.0	0.0	0.0	0.5	0.0	0.4	0.7	0.3	0.0	0.9	9.7	1.6	0.1	0.1	0.0	0.5	100.3	0.1	3.7	5.2	0.2	0.1	2.6	4.8	0.1	0.0	0.0	0.5	0.7	6.8	0.0	0.2	0.0	0.5	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	3.9	0.0	0.0	0.3	0.0	0.0	82.0	0.0	1.2	37.4	78.7	40.6	62.2	54.0	31.6	13.9	19.8	15.6	14.1	20.5	31.3	0.3	0.0	20.1	5.2	4.1	2.3	25.4	16.3	0.0	6.3	0.4	11.7	126.0	2.8	56.1	14.7	4.2	0.0	11.4	7.1	17.6	0.1	19.7	3.2	1.5	3.0	13.1	4.8	43.8	0.0	0.0	7.1	6.1	7.7	1.3	1.3	0.4	8.3	0.1	1.7	5.9	20.6	114.0	1.6	0.7	12.4	0.0	1.5	33.8	10.3	0.7	640.7	0.0	7.1	6.6	0.4	2.8	0.0	0.3	19.0	7.5	190.1	19.9	26.2	0.0	0.2	4.3	6.7	7.3	0.2	1.3	0.1	1.1	0.1	8.2	68.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122227456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	23.8	34.3	29.8	17.3	30.8	32.5	25.3	33.7	36.8	21.4	30.4	28.7	21.7	27.0	36.1	30.8	23.3	18.0	30.3	28.7	32.0	34.5	39.6	21.2	21.0	32.0	31.4	27.8	27.7	32.2	41.4	25.8	32.1	21.9	24.5	27.5	28.9	19.5	37.4	25.4	26.9	20.5	33.6	24.3	26.6	53.2	31.0	26.9	25.8	34.5	24.9	32.0	24.5	33.4	49.0	94.7	65.4	44.7	45.9	44.6	50.2	49.5	48.3	56.9	50.8	82.4	24.9	59.2	45.4	45.2	42.4	47.4	72.2	59.3	67.0	51.1	56.4	65.2	36.6	76.7	65.3	71.0	25.9	62.2	41.3	67.3	100.1	64.4	66.8	57.9	75.9	24.5	56.1	72.4	58.6	103.8	52.9	69.5	88.0	52.3	65.2	65.4	64.4	74.7	61.7	62.6	66.1	26.2	54.8	73.3	87.9	49.2	46.0	43.7	53.6	50.0	45.4	52.8	95.5	84.3	55.8	53.6	58.8	43.3	39.8	39.8	39.9	41.4	37.8	46.3	36.4	37.2	48.3	36.4	35.6	36.1	17.9	45.5	40.1	37.5	46.3	42.0	29.8	30.8	33.7	36.8	28.7	32.0	32.0	31.4	32.1	33.6	31.0	33.4	0.2	0.0	0.6	7.2	19.7	5.0	5.9	7.6	31.3	7.3	0.0	0.0	1.3	10.0	3.3	0.0	4.2	11.3	3.0	8.2	0.0	0.2	6.3	0.0	0.0	3.8	7.3	20.4	14.5	0.0	10.8	7.7	25.5	0.0	4.5	0.0	5.3	2.9	6.5	3.3	14.1	8.8	8.2	3.3	3.6	4.6	5.6	7.1	3.6	3.7	2.7	7.6	9.2	9.0	15.1	0.2	11.9	3.4	29.2	3.9	16.8	0.1	1.7	11.1	6.6	2.6	4.9	19.2	16.3	30.4	4.8	13.4	13.2	0.0	9.9	3.9
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease variant, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 564.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004916, HPA076913"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		2000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	27.9	20.3	21.0	42.1	22.5	90.2	24.2	18.3	20.9	24.4	40.0	31.0	40.6	18.5	44.3	58.0	25.2	30.0	34.9	21.5	25.7	38.1	91.7	51.3	67.0	18.8	19.9	12.9	37.3	44.6	24.5	25.1	20.1	14.7	31.1	28.4	36.1	19.3	172.0	47.3	36.5	18.7	18.0	36.3	45.1	19.9	27.4	68.5	33.1	55.7	66.4	47.1	30.4	18.6	147.8	92.6	53.2	68.4	40.4	54.5	71.3	59.5	62.2	67.7	70.2	318.1	131.6	156.5	88.1	85.5	103.0	157.9	116.9	191.5	84.8	88.9	66.6	282.6	121.4	103.6	37.7	198.9	564.7	34.4	102.1	94.5	95.5	30.5	87.0	234.8	101.2	106.9	67.7	141.5	217.2	256.8	51.6	75.2	61.6	240.1	87.1	87.6	129.8	158.5	69.4	37.3	146.2	184.6	59.5	47.5	77.5	92.1	52.8	93.9	49.9	52.1	119.9	54.2	94.4	111.7	50.2	153.7	57.8	23.6	12.8	29.8	32.6	14.0	21.2	9.3	20.3	25.3	12.6	9.1	14.8	23.9	13.7	13.7	15.1	10.0	18.7	15.4	21.0	22.5	18.3	20.9	21.5	25.7	18.8	19.9	20.1	18.0	27.4	18.6	33.9	48.1	46.8	11.8	40.0	52.6	60.8	22.4	21.6	17.3	35.1	23.1	18.6	22.8	48.0	44.1	54.2	20.9	96.9	60.5	5.9	62.7	27.9	42.3	18.9	39.0	5.4	52.6	44.1	98.0	31.9	25.9	76.0	83.0	46.9	14.5	16.8	91.6	17.1	6.7	33.6	23.1	12.2	38.4	60.6	9.0	11.8	78.5	19.6	24.4	54.6	12.1	115.4	25.6	9.1	122.9	35.7	10.9	54.1	77.3	35.2	13.9	30.4	69.0	13.1	15.4	26.4	18.3	26.1	38.7	59.7	52.1	92.8	18.3	30.1	91.2
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163928	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;testis: 18.9"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 414.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032151			Supported	"Plasma membrane,Microtubules"		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Microtubules"		"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.04e-4)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	0.4	0.1	0.1	1.7	0.2	7.1	0.8	0.3	0.3	0.3	0.2	1.9	1.9	0.6	0.0	2.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	1.2	2.4	0.2	0.3	0.1	0.2	0.1	0.0	3.5	0.2	0.1	2.1	0.0	0.5	0.0	0.0	1.3	1.6	2.6	0.1	0.5	1.6	18.9	0.3	5.4	0.1	0.0	2.4	0.6	0.7	0.2	47.7	15.6	15.8	9.1	2.7	7.1	26.9	65.0	28.7	64.2	55.6	41.7	31.4	15.9	5.2	33.4	16.7	31.7	26.0	25.5	96.9	18.0	17.9	22.7	37.6	9.5	4.1	31.2	17.4	2.8	0.6	39.2	26.3	16.3	29.2	14.0	17.8	21.9	61.8	6.9	28.0	10.2	14.7	22.5	8.9	18.8	38.9	12.9	19.9	9.6	8.3	14.3	33.2	22.8	9.5	33.8	16.7	16.8	29.3	40.5	25.9	13.7	54.5	14.7	17.1	24.4	10.9	15.2	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.2	0.6	54.5	3.4	39.8	1.9	3.7	0.8	2.1	2.8	0.0	3.9	1.5	1.0	2.8	1.8	0.0	0.0	21.1	1.1	3.8	5.9	1.3	414.4	2.5	3.5	2.1	0.0	26.7	5.6	4.0	30.7	5.8	9.7	9.3	0.0	78.8	1.8	0.4	6.1	0.0	3.3	2.6	2.0	1.0	1.2	56.0	0.6	1.5	0.0	5.6	0.1	3.5	2.1	19.1	1.8	1.5	0.2	0.0	18.9	0.4	1.1	5.4	0.2	0.0	0.0	0.0	7.9	39.2	17.8	11.6	1.1	7.3	2.2	2.8	5.6	1.5
DMXL2	"DFNA71, KIAA0856, RC3"	ENSG00000104093	"Dmx like 2"	Q8TDJ6	15	51447711-51622833	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.2;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"U-937: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039375	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA039375: AB_10673610"	"unprognostic (5.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.70e-2)"	5.3	4.7	4.1	11.1	4.7	17.1	3.4	4.0	7.3	4.6	8.1	6.5	9.2	4.4	13.9	1.9	5.2	4.5	3.1	8.9	2.8	5.7	4.5	6.8	4.7	2.5	1.1	4.1	5.4	8.0	8.4	7.2	3.0	2.7	7.5	16.3	5.4	2.5	1.1	1.7	7.1	5.3	0.0	6.5	5.3	9.0	4.2	4.7	4.2	1.7	2.6	6.0	2.8	2.4	9.1	11.7	12.6	7.3	5.3	9.1	3.1	6.9	7.5	6.5	8.5	1.7	4.4	0.0	3.3	4.1	12.5	4.8	8.1	4.8	8.7	10.6	3.9	3.6	10.6	2.1	4.9	20.6	5.8	4.2	3.9	8.4	3.7	6.8	4.5	10.9	8.3	0.8	6.7	10.0	8.9	19.2	9.2	4.3	3.8	7.9	10.3	13.5	3.4	18.1	18.0	7.8	7.3	4.1	8.5	11.0	6.9	21.9	5.7	7.8	5.3	11.0	8.2	16.0	25.2	0.0	9.2	44.0	7.4	0.0	2.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.2	0.0	2.7	0.3	0.0	0.4	4.1	4.7	4.0	7.3	8.9	2.8	2.5	1.1	3.0	0.0	4.2	2.4	5.2	3.2	15.7	68.6	2.1	3.1	2.5	4.1	4.6	41.4	4.9	2.0	8.4	1.5	6.7	7.3	64.6	5.7	13.1	22.7	1.9	3.0	2.5	11.6	18.9	5.4	28.1	0.8	138.9	3.8	4.9	8.7	28.5	5.5	10.8	10.6	5.7	6.0	36.5	58.9	122.9	13.3	2.0	96.1	16.4	3.5	6.5	106.3	3.6	50.6	84.9	8.6	1.0	96.5	50.7	5.2	17.4	9.1	2.1	2.5	24.9	8.1	18.7	31.9	6.6	8.1	8.7	37.2	30.3	2.8	1.7	3.8	3.6	9.1	15.9	2.7
DSPP	"DFNA39, DGI1, DMP3"	ENSG00000152591	"Dentin sialophosphoprotein"	Q9NZW4	4	87608529-87616873	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Deafness, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036230	Uncertain				"Secreted in other tissues"	NA	NA		27000							"HPA036230: AB_10672239"				"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.27e-1)"		"unprognostic (2.21e-2)"				"unprognostic (1.26e-1)"			"unprognostic (1.76e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELMOD3	"DFNB88, FLJ21977, RBED1, RBM29"	ENSG00000115459	"ELMO domain containing 3"	Q96FG2	2	85354394-85391752	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012126	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA012126: AB_1848130"	"unprognostic (1.90e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.63e-2)"	"prognostic favorable (6.16e-6)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (5.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.85e-5)"	11.1	8.2	7.0	3.7	7.4	2.7	8.7	6.6	8.0	7.2	5.1	7.6	4.9	5.6	5.9	5.0	6.9	6.1	5.3	5.9	6.4	6.0	8.8	4.9	5.4	6.9	6.8	6.5	6.0	8.9	6.6	6.1	6.2	8.4	4.9	3.1	6.2	7.0	12.1	5.1	5.6	6.7	6.4	6.6	7.1	2.7	6.7	5.4	6.3	10.2	5.0	7.3	6.3	7.0	4.9	6.0	6.7	10.0	20.9	9.2	4.0	8.6	6.7	12.6	11.7	5.0	2.4	3.7	6.7	7.2	15.9	5.1	9.7	11.9	11.4	13.0	6.7	6.5	3.4	3.7	10.9	4.9	8.2	9.6	10.6	12.1	13.6	10.6	9.1	7.4	6.6	4.2	11.9	3.9	7.2	2.9	3.3	9.8	6.4	5.2	13.9	3.5	5.8	3.0	6.3	3.3	5.3	7.3	7.9	7.6	4.0	3.5	4.8	9.1	4.9	7.9	8.0	5.0	9.9	4.9	9.1	5.7	9.4	6.5	2.7	8.0	5.0	1.9	2.7	3.1	3.2	2.0	3.2	2.6	2.7	4.8	2.5	5.0	4.5	0.9	5.5	2.8	7.0	7.4	6.6	8.0	5.9	6.4	6.9	6.8	6.2	6.4	6.7	7.0	9.0	6.4	8.4	36.9	15.7	4.7	10.0	13.0	8.6	27.2	10.7	7.6	5.2	10.0	16.7	11.0	29.2	15.2	9.8	17.3	7.9	8.6	5.6	4.6	6.9	9.5	8.4	7.4	24.3	9.1	5.9	10.0	12.8	4.0	8.9	20.7	12.5	7.5	8.6	30.3	21.4	11.4	14.2	10.0	9.3	5.6	19.3	9.5	17.8	18.7	16.5	14.1	28.8	28.6	49.7	10.4	15.3	23.7	7.7	10.8	24.9	7.1	11.7	30.9	19.7	10.0	8.0	19.7	10.9	6.7	6.5	12.4	14.0	18.3	12.7	9.4
EPS8		ENSG00000151491	"Epidermal growth factor receptor pathway substrate 8"	Q12929	12	15620134-15882329	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 317.0;Sertoli cells: 401.0;Smooth muscle cells: 313.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 22.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 253.0;HHSteC: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003897	Approved		Approved	"Golgi apparatus"		NA	NA		17000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA003897: AB_1848224"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (2.68e-1)"	"prognostic favorable (1.45e-7)"	"unprognostic (7.47e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.79e-2)"	62.3	13.0	12.9	16.1	17.4	0.6	33.7	15.3	14.0	53.9	14.1	49.7	37.6	46.2	47.1	20.5	20.1	56.0	26.4	11.1	17.2	55.8	37.8	29.0	9.4	18.5	20.1	49.2	15.1	21.6	3.5	53.1	19.7	16.4	53.7	39.8	13.4	39.8	13.8	11.9	42.7	53.7	15.5	11.9	32.0	15.6	16.1	4.8	22.8	24.3	5.2	51.7	21.4	20.8	65.0	38.8	37.7	1.4	253.0	177.6	53.1	73.6	59.8	34.5	46.1	33.3	97.3	0.0	2.4	140.4	114.4	16.4	11.3	9.5	52.4	0.2	12.6	5.7	11.2	34.7	218.1	4.4	0.2	159.8	42.8	91.7	115.7	44.6	17.7	0.2	0.1	0.2	169.0	17.5	0.2	2.8	5.2	50.3	30.8	0.0	109.5	0.8	97.7	92.5	3.1	4.9	21.4	12.4	91.5	6.2	34.2	4.3	28.7	54.7	14.3	32.4	30.7	3.6	0.4	0.1	32.1	10.7	160.0	0.0	2.7	0.2	0.2	10.8	0.1	1.3	0.9	0.4	5.5	0.3	1.1	0.5	4.4	1.0	22.2	0.4	0.1	1.7	12.9	17.4	15.3	14.0	11.1	17.2	18.5	20.1	19.7	15.5	16.1	20.8	121.4	12.8	175.9	91.1	11.6	17.0	39.6	32.0	13.6	9.7	28.7	42.8	27.6	87.2	58.3	23.9	66.7	33.0	15.2	317.0	60.7	69.4	67.6	87.4	72.0	61.4	38.3	0.4	2.2	68.9	7.3	73.4	81.1	152.2	6.3	139.4	36.0	36.0	65.8	6.7	31.1	54.5	67.1	54.1	35.6	49.4	134.8	46.2	35.6	148.0	8.6	15.4	0.0	121.2	96.9	97.0	217.8	43.6	5.2	26.9	69.0	114.6	104.8	153.7	401.0	18.1	313.1	10.9	4.2	22.8	13.1	21.1	11.8	40.0	80.0	97.6
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 188.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 211.4;Paneth cells: 175.3;Proximal enterocytes: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 3.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 234.3;BEWO: 220.8;CAPAN-2: 206.6;SK-BR-3: 257.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 9.2"	HPA041143	Approved		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	7.8	11.2	5.2	5.7	4.8	0.0	27.0	8.9	5.5	49.4	4.9	42.7	100.8	11.4	3.5	188.5	19.2	13.3	4.3	4.5	6.8	98.4	101.7	32.4	0.7	10.9	9.2	11.8	43.7	3.8	11.5	17.7	6.2	29.3	15.5	1.0	94.6	15.2	1.3	76.3	105.0	2.9	7.1	1.4	48.1	3.2	7.1	2.0	70.2	0.4	10.9	17.5	80.1	6.5	234.3	68.6	0.2	1.6	2.7	14.4	220.8	20.1	20.3	29.2	12.5	51.4	206.6	0.4	81.6	21.4	5.4	122.4	0.6	117.8	6.4	0.6	5.4	0.0	27.7	94.7	16.3	0.3	0.4	8.1	77.8	8.0	18.7	12.3	0.2	0.1	1.8	1.1	3.2	72.1	0.5	1.3	2.7	71.5	24.0	0.5	0.8	1.8	103.8	55.2	0.8	0.8	75.9	257.5	0.5	14.3	94.9	0.2	1.5	11.2	27.3	7.2	1.6	0.9	1.0	0.8	6.1	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.1	5.2	4.8	8.9	5.5	4.5	6.8	10.9	9.2	6.2	7.1	7.1	6.5	1.8	141.1	51.8	3.9	11.2	19.8	26.2	48.8	51.8	0.6	39.1	37.0	4.5	57.2	62.4	90.1	0.0	47.9	21.6	211.4	27.4	55.2	1.0	47.3	7.1	4.7	43.8	1.3	3.1	80.0	33.4	11.5	131.0	60.8	7.0	0.4	0.7	59.4	4.7	0.0	3.8	76.8	32.6	2.1	7.8	2.3	18.0	2.7	14.2	2.8	3.1	10.0	16.5	2.0	0.7	83.2	175.3	11.7	7.6	33.6	235.9	108.2	60.9	1.5	0.0	0.9	7.5	1.1	4.8	74.9	24.4	92.5	18.6	0.9	77.2	32.1
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 129.1;retina: 117.8;testis: 145.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.4;thalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	5.7	0.4	2.6	1.0	28.0	9.2	13.4	1.0	30.3	0.2	28.2	90.4	2.4	39.9	34.3	18.6	0.3	0.9	0.4	1.7	63.4	129.1	3.2	0.3	0.6	1.3	0.4	0.9	26.8	42.1	0.9	1.1	10.0	6.8	117.8	9.4	6.2	0.8	91.7	89.5	0.8	0.3	0.9	2.7	145.3	6.1	1.6	0.4	0.0	1.7	1.3	22.3	0.5	14.1	0.7	0.6	0.1	0.0	0.0	48.9	0.0	0.0	0.2	0.0	29.9	1.5	0.5	6.5	0.0	0.1	32.6	2.3	0.1	0.0	2.0	0.7	0.4	0.7	81.5	0.0	0.6	2.7	0.1	0.6	0.0	0.0	0.0	0.0	1.0	17.6	0.0	0.0	28.2	0.2	1.0	0.6	3.8	12.2	0.0	0.4	10.9	0.2	0.1	21.0	0.7	3.7	160.1	5.0	0.3	53.6	7.4	15.6	0.1	0.8	0.6	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	13.4	1.0	0.4	1.7	0.6	1.3	1.1	0.3	6.1	0.5	0.2	0.0	0.6	0.0	0.8	7.8	2.4	4.5	12.5	5.6	10.7	3.9	1.4	11.5	3.8	9.2	68.8	3.0	0.2	175.5	13.7	0.2	137.5	19.1	0.9	0.8	6.0	8.2	0.2	3.1	0.5	0.3	5.6	12.4	0.0	0.0	3.9	109.4	0.2	0.0	0.2	36.3	8.2	3.2	0.9	461.6	3.7	1.5	0.0	0.0	0.0	272.5	0.0	0.0	0.1	0.1	186.3	2.2	0.0	1.6	512.1	102.2	9.0	72.5	0.0	0.0	0.2	12.3	3.9	17.6	22.7	6.6	1.5	0.0	35.3	2.9
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.2	0.0	0.0	5.2	0.0	0.0	24.2	0.0	0.0	15.5	0.0	57.1	25.2	3.4	29.6	64.2	21.3	8.5	0.1	0.0	0.0	8.5	0.4	15.8	0.0	0.0	0.1	0.1	42.6	28.4	7.2	12.2	0.0	19.9	62.8	0.0	25.9	10.0	0.1	60.6	22.0	2.5	0.0	0.0	38.6	0.6	0.4	5.2	36.6	0.0	15.3	22.5	28.8	0.0	138.3	0.0	0.0	0.2	0.0	0.0	101.1	0.0	0.0	0.0	0.0	44.6	140.8	0.0	3.8	0.0	0.1	81.6	3.8	70.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	226.5	0.0	1.4	0.0	0.0	10.7	0.0	0.0	0.0	67.3	1.9	0.4	12.4	142.6	3.4	0.0	0.0	18.3	17.4	99.1	35.1	0.3	0.0	21.0	14.0	21.4	108.0	0.9	0.0	0.1	0.2	0.1	0.3	12.0	13.8	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	38.5	36.7	0.0	0.6	44.6	18.9	30.4	35.9	0.0	29.4	18.0	1.0	21.5	32.4	27.6	0.0	55.1	0.5	76.2	13.7	19.6	12.9	47.1	3.7	0.9	33.1	0.0	2.6	27.5	69.1	0.9	58.1	46.5	1.3	0.0	0.4	0.1	6.0	0.0	0.4	107.2	16.2	0.0	3.2	10.3	0.0	0.5	24.9	0.0	0.6	0.0	0.0	0.5	0.4	21.7	48.1	0.7	1.8	25.1	25.5	0.3	35.0	0.0	0.0	0.0	1.2	0.6	0.9	71.3	79.1	62.1	0.8	0.0	73.9	40.1
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 36.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.9	0.3	0.6	6.6	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	36.5	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.1	2.4	1.2	0.9	0.1	0.0	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.2	2.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.3	0.6	1.5	1.2	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.4	5.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	13.7	0.0	14.1	0.0	0.0	0.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	2.0	0.0	0.0	0.0	0.0	37.6	0.0	0.1	0.0	3.7	0.0	4.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.3	0.0	0.1	0.8	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
FDXR	"ADR, ADXR"	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 343.1"	"Group enriched"	"Detected in many"	7	"Granulosa cells: 329.3;Theca cells: 794.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 89.5;Hep G2: 173.5"					"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	3.9	343.1	6.9	2.4	8.4	2.2	3.8	7.8	8.1	7.8	8.6	9.7	4.6	6.7	5.1	26.0	12.9	4.1	6.0	6.6	6.7	6.5	14.9	5.3	2.9	7.6	7.9	20.5	12.9	5.9	4.1	3.0	7.5	6.7	3.2	0.5	7.1	4.4	7.7	16.4	5.6	2.3	7.4	33.9	7.6	45.6	7.0	4.7	6.0	1.7	2.5	6.2	10.5	7.5	12.5	65.6	9.6	10.8	6.8	9.1	89.5	14.8	15.9	8.6	17.1	18.3	10.8	29.6	2.6	6.2	4.8	24.9	6.9	18.4	2.5	27.9	15.2	22.6	10.6	173.5	19.0	5.0	75.1	29.2	20.3	9.1	3.1	7.0	43.9	10.9	36.1	4.8	13.4	53.4	19.7	10.6	5.5	11.8	14.5	10.6	16.4	16.2	7.1	21.0	5.2	12.1	10.0	21.7	11.2	10.9	47.4	4.7	20.5	5.9	51.9	9.4	7.4	12.7	2.3	6.5	16.1	7.7	20.6	1.7	6.0	5.0	5.6	4.5	5.0	4.8	5.1	6.8	7.3	2.4	4.4	5.4	2.0	10.3	3.4	1.4	15.4	5.2	6.9	8.4	7.8	8.1	6.6	6.7	7.6	7.9	7.5	7.4	7.0	7.5	4.0	3.2	3.9	7.5	8.2	9.7	17.8	42.6	17.1	4.9	6.6	8.4	3.8	5.7	23.3	9.2	4.2	53.2	2.8	18.6	5.9	11.1	6.5	28.2	4.3	4.6	7.1	4.0	1.4	7.9	18.9	12.9	13.7	3.5	5.7	329.3	12.5	13.9	23.1	3.3	2.2	13.1	36.7	6.2	2.7	14.9	5.9	4.6	5.4	1.0	3.9	11.4	8.2	3.0	1.3	9.0	16.9	4.5	7.1	5.2	24.9	21.7	73.6	5.1	0.0	6.2	18.3	6.3	6.1	33.7	18.2	46.1	8.6	794.1	20.3	17.4
GAB1	DFNB26	ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center, Plasma membrane"	Cytosol	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	7.9	8.6	23.3	6.7	69.9	11.5	9.9	35.5	30.0	10.6	2.5	19.7	12.1	18.1	14.2	20.4	9.2	12.5	30.5	20.4	34.6	13.9	9.1	17.9	6.1	57.3	45.4	19.5	8.1	11.3	4.3	21.0	47.9	8.5	22.8	6.9	8.9	14.7	13.4	10.7	12.3	17.7	26.4	7.5	11.3	9.2	45.7	5.4	7.5	16.5	8.7	7.1	9.7	114.8	6.7	1.4	16.7	12.1	8.3	7.9	22.0	4.6	15.2	5.4	9.4	12.8	11.2	0.2	1.4	6.5	3.7	3.8	16.2	5.3	6.2	1.0	3.9	12.2	3.7	6.1	5.7	1.6	2.3	9.7	9.5	6.6	4.3	11.5	7.2	0.2	4.1	21.7	3.8	9.7	0.9	0.0	4.8	3.5	5.3	74.6	8.2	8.8	8.4	8.0	3.9	11.8	3.1	13.3	5.6	11.2	8.5	1.6	5.5	6.9	5.4	3.4	3.5	34.6	18.2	26.3	4.7	4.8	5.7	4.1	0.4	0.5	0.0	0.5	0.2	0.9	0.0	0.0	0.5	1.8	0.0	0.0	2.6	5.0	1.7	2.2	0.0	0.3	23.3	69.9	35.5	30.0	20.4	34.6	57.3	45.4	47.9	26.4	45.7	114.8	13.4	28.9	19.0	89.5	13.1	20.3	8.8	3.3	12.0	2.1	11.6	8.9	34.0	8.6	5.3	12.9	0.0	23.5	10.9	26.2	0.0	6.6	0.9	8.8	9.3	16.3	22.2	40.8	162.7	2.6	10.6	14.4	11.2	21.6	2.5	9.6	13.9	7.0	6.1	3.3	62.2	27.8	4.1	11.6	10.2	3.8	20.8	8.8	16.0	192.0	5.6	15.4	1.0	288.0	1013.6	4.9	10.7	18.8	94.4	7.2	9.3	5.4	3.4	0.8	13.1	7.0	14.3	2.0	5.3	19.9	24.9	10.4	2.7	4.4	13.6	13.5
GIPC3	"C19orf64, DFNB15, DFNB72, DFNB95"	ENSG00000179855	"GIPC PDZ domain containing family member 3"	Q8TF64	19	3585478-3593541	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.7"	"Group enriched"	"Detected in some"	4	"Adipocytes: 10.4;Endothelial cells: 6.2;Hepatic stellate cells: 12.8;Rod photoreceptor cells: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 19.0;HMC-1: 11.8;THP-1: 23.1;WM-115: 44.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067765			Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA067765: "	"unprognostic (1.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	4.6	2.2	1.4	1.0	1.0	0.3	2.8	1.0	1.1	3.0	0.8	1.9	1.2	2.8	2.9	5.2	2.1	2.1	3.9	1.2	1.2	3.6	1.4	3.8	2.4	1.6	1.2	0.7	0.7	2.7	1.0	1.1	1.6	3.5	1.4	16.7	0.7	2.3	1.7	1.1	4.4	8.3	1.4	3.9	2.0	0.3	1.6	3.1	3.0	1.9	1.6	1.1	1.8	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.9	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4	0.0	1.5	0.0	0.2	6.9	19.0	0.0	0.7	0.0	11.8	0.2	0.0	1.1	0.0	0.0	2.1	0.2	3.2	0.0	0.3	0.0	0.0	1.1	0.7	0.0	1.2	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.5	0.0	4.7	1.1	0.0	23.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.0	1.1	1.2	1.2	1.6	1.2	1.6	1.4	1.6	1.1	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.1	0.3	2.4	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	12.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.8	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.2	1.1	0.0	0.4	0.1	0.3	0.1	0.3	0.1	0.0	0.1
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20192938	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 328.1;esophagus: 812.1;vagina: 519.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.8;Basal respiratory cells: 237.4;Basal squamous epithelial cells: 55.8;Ionocytes: 50.8;Squamous epithelial cells: 160.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 144.6;hTCEpi: 105.4;OE19: 76.9;RT4: 169.9"	"Low region specificity"	"Detected in all"							"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	2.0	0.7	1.3	6.7	1.2	3.8	3.7	2.4	3.1	328.1	5.3	20.8	12.9	2.9	3.4	812.1	0.9	14.0	0.4	1.1	1.7	9.8	47.5	0.7	0.4	1.8	1.7	0.3	1.3	0.1	4.1	0.2	1.7	1.2	17.4	0.0	145.2	0.3	0.4	73.0	10.6	2.6	1.7	0.2	8.1	1.2	7.6	12.5	1.7	1.2	90.4	27.9	519.8	1.6	8.7	0.6	0.0	0.2	0.0	2.9	1.7	0.0	0.0	0.0	0.0	1.3	144.6	0.0	0.7	0.1	1.1	28.9	5.3	14.4	0.1	12.6	1.8	0.1	0.1	0.3	0.0	0.0	5.1	2.4	105.4	1.9	19.5	0.0	0.0	2.1	0.1	10.7	0.2	1.4	1.3	0.0	0.3	76.9	14.4	0.2	0.0	8.3	0.2	169.9	0.1	0.0	0.3	0.1	0.3	1.9	2.2	0.4	0.0	0.2	0.0	2.5	22.2	8.7	9.6	0.0	17.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.4	3.1	1.1	1.7	1.8	1.7	1.7	1.7	7.6	1.6	0.1	3.2	0.0	2.0	0.6	69.8	16.1	237.4	55.8	0.0	1.3	1.3	0.5	4.3	37.3	1.8	0.0	0.1	0.0	28.0	0.0	4.4	1.5	5.0	1.5	1.3	4.2	0.0	0.0	9.8	0.2	1.7	4.1	19.1	0.0	0.0	0.0	25.2	0.6	0.0	0.0	6.1	50.8	0.6	13.3	1.3	0.0	3.9	1.8	0.0	4.6	0.0	0.0	0.0	0.0	9.2	13.3	0.0	2.7	8.6	10.7	17.5	7.5	0.0	0.0	0.1	4.7	0.8	2.1	160.9	28.7	0.1	0.9	0.0	25.0	21.7
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781214-34786369	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 77.8;skin 1: 145.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 138.4;Basal prostatic cells: 71.9;Basal respiratory cells: 43.6;Pancreatic endocrine cells: 119.8;Prostatic glandular cells: 63.4;Squamous epithelial cells: 91.9;Suprabasal keratinocytes: 170.6;Urothelial cells: 171.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 58.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 88.8;CAPAN-2: 121.7;HaCaT: 99.4;HBEC3-KT: 84.9;hTCEpi: 136.8;OE19: 54.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.3	0.2	1.3	1.7	0.6	0.0	5.5	1.1	1.0	8.9	0.0	4.2	0.2	0.3	2.8	77.8	1.1	7.0	0.1	0.6	0.0	0.5	1.5	0.6	0.5	0.2	0.0	0.1	0.3	0.0	0.1	1.4	0.1	4.0	5.0	0.0	8.9	1.7	0.6	145.0	1.3	0.1	0.0	0.0	5.9	0.8	0.1	0.8	0.2	0.0	12.9	11.9	26.4	0.2	88.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	121.7	0.0	11.6	0.1	0.1	99.4	0.0	84.9	0.0	0.1	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	35.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.4	54.2	22.3	0.0	0.0	0.0	40.8	33.0	0.0	0.0	13.1	0.9	0.0	0.1	1.0	0.1	0.0	0.1	5.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	1.1	1.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	3.2	0.0	0.0	0.0	138.4	71.9	43.6	16.5	0.0	2.0	1.3	0.4	1.5	15.5	5.5	0.0	0.3	0.0	18.3	0.0	14.6	0.0	4.1	0.4	1.7	1.8	0.0	0.2	7.3	0.2	1.7	3.1	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	6.1	0.0	12.5	0.0	0.0	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	119.8	8.1	0.0	0.0	63.4	0.5	0.0	10.1	0.0	0.0	0.0	2.1	0.1	0.3	91.9	170.6	0.1	0.5	0.0	19.1	171.0
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232365	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.6;esophagus: 195.4;vagina: 139.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 58.8;Basal keratinocytes: 12.2;Basal respiratory cells: 15.6;Ionocytes: 12.2;Squamous epithelial cells: 31.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.6"	"Cell line enriched"	"Detected in some"	10	"RT4: 186.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA014846: AB_1847135"	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	0.5	0.2	55.8	0.3	59.4	95.6	3.8	73.0	80.9	65.9	36.0	0.0	0.0	0.9	0.2	195.4	0.4	1.3	0.1	50.2	63.5	0.0	0.1	0.3	0.8	60.0	71.8	0.0	0.1	0.0	4.4	0.0	57.5	0.2	0.1	0.0	34.5	0.0	0.1	56.8	0.2	0.0	47.7	0.2	0.3	1.4	76.3	37.6	5.3	0.0	15.4	10.3	139.3	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	4.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	186.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	1.1	0.6	0.5	0.0	0.0	0.0	2.6	0.2	55.8	59.4	73.0	80.9	50.2	63.5	60.0	71.8	57.5	47.7	76.3	42.7	0.0	0.0	0.0	58.8	0.0	12.2	1.7	15.6	4.0	0.0	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.9	5.8	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	12.2	0.0	0.4	4.6	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.3	31.0	3.8	0.0	0.3	0.0	0.0	2.4
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.9;tongue: 54.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 133.5;Oligodendrocyte precursor cells: 134.7;Oligodendrocytes: 127.4;Syncytiotrophoblasts: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;T-reg: 1.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;T-cells: 1.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	5.3	3.5	27.3	4.4	39.5	14.4	7.5	33.8	25.2	12.6	10.8	15.3	9.1	6.8	2.6	34.1	4.2	2.6	4.3	23.3	29.5	2.3	2.9	9.0	6.4	33.9	36.3	3.3	3.6	9.7	3.1	7.7	33.9	5.9	15.2	8.6	10.1	4.7	10.7	37.7	11.5	10.5	32.1	2.7	5.1	11.5	34.1	18.4	3.2	54.4	13.2	6.0	17.7	46.9	135.6	16.2	36.8	27.7	36.4	20.2	30.0	24.2	61.4	29.9	45.4	16.0	31.7	30.5	6.7	33.4	21.0	28.3	25.3	59.1	39.6	30.7	15.8	19.8	34.7	16.5	4.8	28.6	18.5	4.1	113.9	29.4	129.8	9.4	26.9	19.5	14.9	42.3	58.4	37.8	26.1	12.2	8.7	52.1	29.4	20.1	66.7	6.6	24.3	18.6	30.4	26.9	37.0	69.2	26.9	10.3	27.6	24.3	18.0	21.7	36.7	64.8	48.5	18.4	20.9	28.6	34.3	47.4	108.9	0.1	0.3	3.2	0.2	0.3	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.3	0.3	0.1	0.1	0.1	1.8	0.1	27.3	39.5	33.8	25.2	23.3	29.5	33.9	36.3	33.9	32.1	34.1	46.9	4.6	16.0	3.3	63.0	5.7	62.7	18.8	12.9	47.3	47.7	3.0	3.7	2.5	2.8	12.5	7.3	133.5	46.3	6.7	10.8	11.7	2.5	54.0	5.2	20.6	5.1	9.1	33.9	11.7	1.9	47.7	19.5	8.6	9.2	2.5	14.4	2.9	1.6	9.0	43.7	24.0	14.1	10.2	5.3	11.3	21.3	18.6	4.9	26.6	3.7	5.3	8.0	2.1	134.7	127.4	4.8	7.8	5.3	5.3	5.6	8.4	0.9	9.0	48.1	0.0	43.6	6.9	20.6	28.9	24.0	40.6	89.2	7.1	10.0	18.7	15.5
GRAP		ENSG00000154016	"GRB2 related adaptor protein"	Q13588	17	19020656-19047011	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.2;B-cells: 21.2;Endothelial cells: 19.8;Hepatic stellate cells: 30.7;Microglial cells: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 99.7;T-cells: 133.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 87.1;HUVEC TERT2: 38.9;JURKAT: 30.1;REH: 47.8;TIME: 70.4;U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046595, HPA066654"	Uncertain		Approved	Centrosome		NA	NA		1400000	"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"HPA046595: AB_10966385, HPA066654: AB_2685699"	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	6.3	3.5	6.7	13.9	6.2	6.5	5.9	6.1	6.9	3.9	5.0	2.6	1.9	3.3	0.5	1.8	4.6	5.3	3.7	5.8	6.1	4.9	6.0	7.1	36.9	6.8	6.5	1.8	0.9	0.6	1.9	6.1	6.8	2.7	1.8	0.4	1.6	3.7	1.7	2.4	15.7	3.3	6.5	37.5	2.2	6.3	7.0	31.9	5.5	1.4	30.7	3.6	2.2	6.0	0.0	0.2	4.5	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.1	0.0	87.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	5.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	38.9	30.1	0.2	0.0	0.0	0.2	19.9	1.9	0.9	0.0	0.0	47.8	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	6.8	70.4	0.0	0.2	9.8	0.1	0.1	0.0	60.2	0.1	0.1	0.3	21.5	9.4	1.3	21.5	4.8	21.5	99.7	67.4	28.4	10.5	82.7	133.6	66.5	2.9	21.4	0.4	7.9	62.3	48.9	6.7	6.2	6.1	6.9	5.8	6.1	6.8	6.5	6.8	6.5	7.0	6.0	11.2	6.4	1.8	0.0	21.2	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.6	0.0	0.0	0.1	3.1	0.0	0.0	0.3	2.3	1.1	0.2	19.8	0.0	4.0	0.0	0.0	0.7	0.4	0.0	1.2	2.5	0.1	30.7	0.8	8.2	0.0	0.0	0.4	0.0	4.4	0.7	0.8	0.0	1.9	0.0	9.4	2.9	0.2	2.1	0.0	0.1	0.2	0.0	0.4	3.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.7	0.3	0.0	1.0	0.3	6.9	0.5	0.3	0.0
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GRXCR1	"DFNB25, PPP1R88"	ENSG00000215203	"Glutaredoxin and cysteine rich domain containing 1"	A8MXD5	4	42892713-43030658	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"seminal vesicle: 2.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 3.2;Spermatocytes: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040824	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA040824: AB_10794863"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRXCR2	DFNB101	ENSG00000204928	"Glutaredoxin and cysteine rich domain containing 2"	A6NFK2	5	145858521-145937126	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Early spermatids: 15.1;Late spermatids: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.2;hippocampal formation: 4.1"	HPA059421	Uncertain					NA	NA						"Cluster 34: Spermatids - Unknown function"			"HPA059421: AB_2684010"						"unprognostic (4.71e-2)"						"unprognostic (2.91e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	16.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699010-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"placenta: 311.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 23.8;Fibroblasts: 95.8;Hepatic stellate cells: 25.0;Muller glia cells: 36.2;Smooth muscle cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 94.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 171.6;HHSteC: 135.8;HL-60: 82.4;hTEC/SVTERT24-B: 87.4;Karpas-707: 240.7;U-87 MG: 62.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000	14000	"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	7.9	19.8	1.6	6.3	3.3	12.3	5.2	1.5	7.8	7.2	1.8	4.4	2.6	8.1	3.6	2.9	5.4	16.6	4.7	2.9	3.6	11.8	30.3	19.5	2.2	3.6	2.3	1.8	2.1	2.1	2.4	311.9	4.3	7.2	3.4	14.2	2.4	6.4	0.8	0.9	2.3	7.1	1.8	6.5	3.9	2.4	2.9	1.5	5.6	3.9	1.5	10.4	6.3	3.3	0.0	0.0	0.1	0.0	21.6	171.6	0.1	0.7	33.4	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	135.8	82.4	0.4	41.4	0.0	87.4	0.3	0.0	2.2	0.0	0.1	240.7	0.6	0.0	0.0	56.4	0.0	0.0	0.2	0.8	0.0	7.5	0.0	0.0	0.2	9.3	0.0	0.1	0.0	0.2	0.0	3.5	0.4	2.0	0.0	0.1	0.0	0.1	0.0	0.0	62.6	16.9	0.1	94.0	15.2	3.9	0.0	18.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	3.2	0.0	17.3	1.0	0.0	4.3	1.6	3.3	1.5	7.8	2.9	3.6	3.6	2.3	4.3	1.8	2.9	3.3	6.2	0.0	4.1	16.3	0.0	1.0	0.2	0.0	1.8	0.2	0.3	0.5	1.3	1.5	0.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	15.2	1.0	23.8	6.2	0.0	2.1	0.3	0.0	4.9	95.8	0.5	0.9	1.3	0.0	25.0	0.5	18.4	0.0	22.4	0.0	0.0	12.5	1.9	2.3	18.3	14.0	1.8	7.5	10.5	36.2	1.0	0.0	0.1	0.0	0.0	10.9	0.3	0.4	0.0	0.0	0.0	0.7	13.1	0.9	26.2	0.2	0.3	0.3	0.1	12.0	0.6	1.3	0.0	0.4
HOMER2	"CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2"	ENSG00000103942	"Homer scaffold protein 2"	Q9NSB8	15	82836946-82986153	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 226.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 215.9;Endometrial ciliated cells: 184.4;Glandular and luminal cells: 151.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 52.7;Karpas-707: 92.6;SCLC-21H: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040134, CAB079014"	Uncertain	Supported	Supported	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB079014: , HPA040134: AB_10795272"	"unprognostic (7.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.75e-4)"	"unprognostic (3.31e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.16e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	1.5	6.3	6.5	1.1	7.6	4.6	26.9	8.2	12.8	23.1	69.8	3.2	8.5	8.4	33.7	21.2	25.9	12.8	21.9	16.2	7.8	7.2	46.4	5.3	1.3	5.7	4.6	2.6	226.2	5.1	7.7	0.6	5.7	57.7	1.0	6.4	71.2	4.6	108.7	45.0	1.3	1.4	4.1	4.8	55.4	6.1	6.0	3.0	28.9	55.9	3.6	1.3	11.7	8.0	16.6	6.9	7.2	18.9	0.2	0.1	1.1	1.1	0.0	1.7	0.6	1.2	11.5	0.1	8.8	8.4	8.3	9.1	52.7	24.9	1.2	45.1	33.5	10.6	0.4	8.3	0.7	0.4	32.6	1.8	37.4	0.6	2.1	1.9	0.0	20.6	0.4	92.6	7.0	48.4	3.2	1.1	11.4	1.4	5.1	2.2	11.5	5.5	25.3	20.1	50.8	13.1	18.6	14.1	17.6	5.2	17.1	3.5	0.2	17.2	31.7	1.3	15.3	11.8	5.9	1.8	29.0	0.4	6.4	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.3	0.1	0.0	0.4	0.0	0.0	0.5	0.2	0.3	6.5	7.6	8.2	12.8	16.2	7.8	5.7	4.6	5.7	4.1	6.0	8.0	1.9	16.0	10.1	24.8	3.8	4.6	56.1	7.2	10.2	15.0	39.7	20.4	23.0	215.9	14.6	11.0	18.8	1.1	4.4	0.3	7.9	29.6	1.9	184.4	15.4	12.4	3.0	8.2	24.8	76.5	0.4	3.6	14.3	151.9	0.0	11.9	1.4	59.6	13.3	20.2	35.1	0.4	0.0	3.2	73.9	4.0	1.8	9.2	37.4	7.5	7.9	18.5	1.0	6.6	11.8	25.9	0.1	0.7	4.1	81.5	0.7	12.1	4.0	5.1	0.0	7.8	4.8	5.5	16.6	19.4	6.0	0.7	3.1	4.1	0.4	30.5
ILDR1	"DFNB42, MGC50831"	ENSG00000145103	"Immunoglobulin like domain containing receptor 1"	Q86SU0	3	121987323-122022247	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Club cells: 14.7;Collecting duct cells: 20.2;Cytotrophoblasts: 16.6;Distal enterocytes: 17.5;Glandular and luminal cells: 13.5;Respiratory ciliated cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.3;HDLM-2: 8.2;MCF7: 5.1;RT4: 7.5;T-47d: 5.3;U-266/70: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018207	Approved				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA018207: AB_1851742"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.46e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.37e-1)"	"prognostic favorable (5.79e-9)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.21e-2)"	0.0	0.7	0.2	1.3	0.1	0.3	2.9	0.2	0.3	11.7	0.1	8.2	3.3	1.0	12.8	3.8	5.1	3.3	0.0	0.1	0.0	6.5	0.2	2.9	1.1	0.1	0.1	0.0	6.7	15.7	2.4	1.8	0.1	6.9	7.2	0.2	8.0	10.6	0.1	1.2	2.4	0.3	0.0	0.6	0.8	0.6	0.1	0.8	7.3	0.0	2.2	2.2	1.1	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	6.3	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.1	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.4	2.8	7.5	0.2	0.0	0.0	0.7	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.1	1.4	1.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	12.8	7.4	0.3	1.3	0.0	0.8	7.5	0.0	0.0	4.2	2.4	0.7	4.3	14.7	20.2	0.0	16.6	0.1	17.5	1.9	7.5	0.2	6.3	1.6	0.1	3.5	0.0	0.5	3.7	0.5	0.1	1.1	13.5	0.0	0.2	0.0	0.1	1.2	0.0	0.5	7.9	8.2	0.6	0.0	0.0	0.0	0.3	1.8	1.9	0.0	0.0	0.0	0.0	0.2	2.6	8.9	0.0	2.1	2.2	2.5	2.1	13.7	0.0	0.0	0.0	0.6	0.0	0.1	5.9	0.6	5.1	0.1	0.0	7.8	3.5
KARS1	"DFNB89, KARS, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase 1"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		82000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	68.5	49.6	45.5	71.6	47.3	86.1	83.0	46.9	63.2	60.3	50.6	75.8	62.4	53.9	75.1	72.5	69.5	50.4	96.0	45.6	48.3	72.2	76.8	53.1	88.3	46.9	47.5	74.9	86.5	76.7	51.5	62.2	46.8	55.2	85.6	69.6	79.6	60.6	213.4	67.3	62.6	69.6	46.8	57.6	66.2	98.9	47.4	96.6	65.3	186.8	107.8	92.1	55.0	48.1	164.2	187.0	133.5	185.4	140.1	140.3	262.4	135.0	164.9	290.2	217.0	332.8	209.0	292.4	145.4	180.8	138.4	229.4	272.0	246.7	314.4	86.0	139.8	161.4	153.1	348.5	255.8	245.5	174.1	166.4	173.8	257.4	414.6	147.7	240.0	253.5	273.4	68.5	222.5	378.0	254.1	262.2	284.3	238.4	135.9	329.2	120.0	358.4	235.4	136.3	200.2	162.9	339.5	122.8	152.2	144.8	166.1	229.2	133.8	159.8	164.9	123.6	196.7	145.1	178.6	696.6	139.5	206.5	199.7	88.6	112.7	130.0	110.7	155.7	202.6	109.5	137.1	132.0	135.7	91.6	126.6	117.1	24.9	127.6	163.1	85.7	155.5	160.5	45.5	47.3	46.9	63.2	45.6	48.3	46.9	47.5	46.8	46.8	47.4	48.1	14.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	0.0	0.0	0.0	0.0	122.7	10.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	143.3	14.4	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	110.0	2.1	0.0	0.0	0.0
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783787-40840452	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.1;intestine: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.1;Inhibitory neurons: 9.7;Muller glia cells: 4.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HEK 293: 2.2;K-562: 2.6;MCF7: 1.4;REH: 1.3;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	0.9	0.1	0.1	0.3	0.6	0.0	0.6	0.2	1.7	0.9	2.4	5.4	0.4	2.8	0.1	1.0	2.3	0.3	0.6	0.2	0.2	0.1	0.1	0.5	0.0	0.7	5.1	0.5	0.4	0.2	0.3	0.5	0.7	1.1	0.3	0.4	1.4	1.1	3.2	0.6	1.2	1.5	0.8	0.0	1.3	0.2	0.1	0.3	0.2	1.0	0.0	2.3	0.7	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.9	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.6	0.2	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	1.7	0.2	0.2	0.7	5.1	0.7	0.8	0.1	2.0	0.3	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	1.8	1.5	2.1	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	1.2	0.2	0.2	0.1	0.3	1.8	0.8	5.1	0.2	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	2.2	0.0	9.7	1.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	2.5	1.5	0.6	0.5	0.7	0.3	0.2	0.0	0.0	0.0	0.3	6.6	2.0	2.8	0.2	0.7	1.0	0.4	0.0	0.0	0.1	1.1	0.1
KITLG	"DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF"	ENSG00000049130	"KIT ligand"	P21583	12	88492793-88580851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Cell adhesion"	"Growth factor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 83.6;Collecting duct cells: 69.9;Excitatory neurons: 46.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 299.8;SK-BR-3: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070395	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		260000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA070395: AB_2686264"	"unprognostic (7.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.61e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.47e-3)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.81e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-2)"	13.2	3.9	2.3	8.2	3.5	0.3	10.6	0.2	3.1	12.9	1.2	18.7	9.6	15.1	2.8	14.3	4.0	18.5	7.0	2.9	0.3	16.0	2.3	31.6	3.3	0.0	2.5	6.0	3.7	3.7	0.2	15.0	0.0	15.1	22.6	2.3	8.8	14.8	3.1	7.1	11.6	18.8	0.3	3.5	17.4	6.3	5.2	5.1	5.9	14.4	10.4	12.3	1.3	6.2	14.3	7.1	7.1	0.9	29.0	61.5	0.0	77.6	60.1	13.5	6.4	299.8	11.0	0.0	2.2	73.3	14.9	49.5	11.5	20.1	14.2	0.1	9.5	0.0	9.5	2.6	4.4	1.9	0.0	53.5	20.6	41.6	26.8	6.3	17.9	0.0	0.0	0.3	6.8	2.5	0.2	0.0	4.8	17.7	17.9	0.0	12.6	0.0	25.0	6.5	2.3	4.8	18.5	118.9	2.2	6.5	57.2	4.3	10.0	60.7	7.4	69.0	6.8	0.0	0.0	0.0	8.4	0.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.5	0.2	3.1	2.9	0.3	0.0	2.5	0.0	0.3	5.2	6.2	42.5	19.2	38.3	9.4	0.5	13.5	11.2	7.5	83.6	2.7	12.2	8.1	4.4	1.5	16.5	69.9	0.0	0.1	0.0	12.0	1.9	4.4	0.4	3.1	6.8	43.1	9.5	0.0	46.5	18.2	0.1	34.5	43.3	3.4	0.0	2.1	5.0	0.4	1.2	21.9	61.4	8.5	18.3	3.2	5.7	0.9	14.0	1.9	12.4	18.7	0.0	0.3	0.0	3.0	0.6	8.7	3.0	3.8	1.4	11.2	2.3	1.4	9.8	1.2	13.1	2.2	27.2	0.2	0.5	18.5	5.3	0.0	1.0	4.4	14.7	3.2
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35797206-35845397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.8;epididymis: 12.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029421, HPA055110"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA029421: , HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.9	1.1	4.1	2.7	4.6	18.8	0.8	4.8	5.6	0.3	0.3	0.9	3.0	1.5	12.4	1.3	0.6	1.7	0.7	3.6	2.6	0.6	0.8	1.0	2.8	0.0	0.3	1.1	5.6	0.3	0.5	1.3	0.2	1.0	0.7	8.2	2.4	0.4	1.4	7.6	2.5	0.3	0.0	2.2	1.7	1.5	1.9	0.5	1.4	0.2	0.6	0.6	0.0	2.7	2.3	1.5	3.0	3.1	0.2	0.6	4.6	1.6	0.3	0.1	0.4	2.7	2.0	3.6	1.2	0.6	1.9	2.9	0.2	0.8	0.3	1.6	2.6	3.2	5.3	4.0	0.0	3.4	2.2	0.5	0.3	0.3	0.4	2.1	0.2	3.6	3.1	5.1	0.9	1.9	2.5	6.2	2.6	0.7	1.5	2.2	1.1	2.0	0.7	5.6	3.4	1.9	1.6	2.3	1.0	2.9	2.4	1.9	2.6	3.1	1.7	2.5	2.4	3.2	3.0	3.1	1.1	3.6	1.6	2.9	0.6	0.5	0.3	0.3	0.3	0.5	0.3	0.3	0.1	0.9	0.4	0.5	3.3	0.6	0.4	0.7	0.4	0.1	4.1	4.6	4.8	5.6	3.6	2.6	0.0	0.3	0.2	0.0	1.9	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.7	0.3	0.0	0.4	8.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
LMX1A	"LMX1, LMX1.1"	ENSG00000162761	"LIM homeobox transcription factor 1 alpha"	Q8TE12	1	165201867-165356715	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"choroid plexus: 20.4"	"Group enriched"	"Detected in some"	16	"Early spermatids: 30.6;Enteroendocrine cells: 41.9;Late spermatids: 23.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA028051, HPA030088"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA028051: AB_10599731, HPA030088: AB_10601106"	"unprognostic (1.73e-1)"		"unprognostic (9.57e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.82e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.22e-2)"			"unprognostic (2.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.82e-3)"		0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.3	20.4	0.3	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	1.3	2.5	0.0	0.1	1.0	0.0	0.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.7	1.3	0.2	2.1	0.5	0.0	2.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.6	0.2	0.0	0.1	41.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 7.2;kidney: 6.9;testis: 23.0"	"Group enriched"	"Detected in some"	70	"Early spermatids: 199.3;Late spermatids: 439.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077128			Approved	"Plasma membrane"		NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA077128: "	"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	2.3	0.0	0.5	0.0	3.4	2.8	0.6	0.0	2.1	0.0	0.1	0.1	0.0	0.1	7.2	0.0	1.7	0.2	0.9	0.3	0.0	6.9	0.0	1.0	0.0	0.0	0.1	0.1	0.2	0.2	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.1	0.0	0.0	0.8	0.1	23.0	0.3	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.0	2.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.9	1.2	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	199.3	0.0	0.1	0.9	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	439.4	1.8	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	4.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	Q96E66	11	72080337-72096895	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 67.1;testis: 49.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 574.9;Late spermatids: 2222.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039949	Approved		Uncertain	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	5.0	4.5	21.1	2.5	21.8	2.1	8.7	19.5	24.2	8.7	25.1	5.4	3.7	7.2	17.1	3.8	67.1	3.4	3.7	19.1	19.2	11.7	7.9	7.7	3.2	23.0	25.7	8.1	8.9	10.3	8.9	5.4	21.4	9.3	7.7	19.7	4.4	5.4	7.5	5.8	3.4	5.7	23.4	4.0	5.5	49.3	21.0	4.5	11.0	4.6	3.6	4.1	3.8	22.0	3.9	13.7	8.9	6.9	7.3	6.7	2.1	4.4	3.6	4.0	3.5	6.6	20.4	5.1	6.6	7.8	9.6	7.3	6.3	10.8	4.5	9.4	6.2	3.5	6.3	4.8	1.3	3.0	3.9	2.9	5.4	6.0	4.6	6.4	1.5	10.2	4.0	7.8	6.0	13.6	9.0	6.0	4.4	22.8	3.6	10.8	8.6	7.7	15.9	4.7	8.2	6.2	8.7	19.4	10.4	6.1	39.6	3.3	6.5	4.0	5.7	11.3	3.1	8.0	9.4	5.8	4.0	2.5	4.5	1.8	1.7	3.5	2.0	1.9	1.9	3.2	2.1	1.6	1.0	3.5	1.8	1.8	6.1	6.6	1.3	2.8	4.6	1.4	21.1	21.8	19.5	24.2	19.1	19.2	23.0	25.7	21.4	23.4	21.0	22.0	4.6	0.0	1.5	3.3	2.5	2.3	7.5	10.0	1.8	3.5	8.4	7.5	2.2	5.7	10.7	3.7	12.5	12.7	1.4	4.4	11.7	7.5	574.9	84.3	3.0	6.5	1.2	3.6	2.0	2.5	7.7	5.3	4.1	7.2	0.0	2.2	3.6	6.0	3.1	6.7	1.9	10.8	10.2	1.6	2.8	2222.2	14.9	3.3	1.8	1.9	1.4	21.3	4.1	2.0	3.6	2.0	2.5	10.1	5.1	6.8	4.0	19.9	113.1	16.6	6.6	6.1	7.9	90.3	28.1	2.2	2.4	13.1	1.7	2.9	3.4	6.5
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672196-116798377	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.6;Club cells: 99.8;Glandular and luminal cells: 161.4;Pancreatic endocrine cells: 93.9;Prostatic glandular cells: 149.3;Urothelial cells: 128.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 7.5;hippocampal formation: 6.6;midbrain: 2.5;pons: 4.9;white matter: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 203.8;CAPAN-2: 219.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	100000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	10.3	0.8	0.1	3.4	0.6	7.4	8.9	0.1	7.5	13.1	9.6	9.7	6.5	6.4	2.5	6.1	4.7	11.9	6.2	6.6	0.8	20.1	42.9	20.3	2.3	1.1	2.5	0.8	6.6	0.8	3.8	26.4	4.9	6.7	9.3	3.9	8.7	11.2	14.3	7.7	8.2	5.7	0.3	6.0	15.4	0.5	0.5	3.7	17.6	11.0	3.2	18.4	4.4	7.8	203.8	115.3	0.1	0.6	8.6	8.7	7.9	113.7	48.2	60.3	51.1	25.0	219.0	8.4	179.0	72.1	163.3	51.8	19.7	110.0	123.7	0.3	23.4	0.1	112.5	21.4	1.5	0.3	0.2	11.4	42.4	40.6	129.1	109.4	42.4	0.2	4.5	0.8	114.1	5.0	0.1	0.1	17.3	32.9	113.0	0.2	95.3	0.2	105.8	24.0	16.5	0.0	45.4	15.4	44.9	19.8	0.4	0.9	72.3	89.7	30.6	46.7	88.9	2.5	19.1	1.5	99.3	0.3	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	7.5	6.6	0.8	1.1	2.5	4.9	0.3	0.5	7.8	32.6	28.9	103.6	0.3	1.0	39.0	70.5	58.1	38.1	6.7	6.5	6.9	12.3	11.5	99.8	31.3	0.0	76.0	0.4	20.5	0.0	38.5	0.0	52.5	11.6	20.1	7.2	0.0	2.6	46.9	7.5	7.4	32.6	161.4	0.0	0.0	3.9	30.5	7.0	0.0	1.0	20.5	18.3	1.3	2.2	0.1	0.6	4.4	3.6	1.9	1.0	7.6	0.0	0.5	7.7	93.9	5.5	0.0	0.4	149.3	11.2	15.6	34.5	0.3	0.0	37.8	5.2	0.0	0.6	7.9	17.8	21.8	1.2	0.0	16.4	128.6
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253416-118264536	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 222.5;urinary bladder: 155.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 38.8"	HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	28.6	4.7	2.5	11.9	2.1	0.7	19.6	2.3	4.8	56.7	5.2	31.1	17.0	16.9	38.5	222.5	46.4	33.5	7.2	2.3	2.6	26.4	23.2	47.0	2.3	3.2	3.0	3.8	13.5	27.1	10.7	1.7	3.2	48.6	30.8	0.9	58.0	69.5	4.7	38.8	11.3	14.7	3.6	4.6	37.0	0.9	3.4	18.1	30.3	1.0	52.6	155.9	120.5	2.8	65.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.0	120.9	0.3	130.4	0.0	0.6	166.9	0.0	38.9	0.0	0.2	9.5	0.1	1.7	35.8	0.0	0.0	0.4	0.0	90.2	0.0	3.0	0.0	86.8	0.8	0.0	0.2	0.0	51.3	0.2	0.2	1.6	34.2	0.1	0.0	0.0	6.4	14.9	321.7	0.1	0.0	5.8	61.4	0.0	0.5	26.1	0.7	351.9	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	2.3	11.6	3.0	0.1	9.2	1.3	0.0	0.6	0.4	17.0	0.0	0.8	0.9	13.2	0.4	1.4	0.3	0.2	3.8	2.5	2.1	2.3	4.8	2.3	2.6	3.2	3.0	3.2	3.6	3.4	2.8	5.9	83.3	123.3	0.0	0.2	332.5	504.4	289.1	127.5	0.0	29.0	17.4	3.4	30.0	221.1	128.8	0.0	1.7	0.5	52.0	0.0	39.4	0.0	91.6	18.8	33.6	5.3	3.6	0.0	51.1	0.2	8.2	29.6	194.0	7.0	0.0	45.3	16.5	0.8	0.0	0.0	6.3	81.4	6.4	27.0	0.3	0.0	7.8	21.4	1.9	4.9	0.0	1.0	0.0	0.0	68.2	20.8	0.0	1.2	186.3	3.3	6.9	65.2	0.0	0.0	0.3	9.2	0.2	0.7	336.4	467.4	17.8	5.4	0.0	33.4	489.7
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	44.9	10.7	12.9	20.9	13.6	21.2	26.3	12.5	12.8	29.5	18.8	108.0	11.9	85.8	20.1	63.0	41.4	33.2	90.8	11.9	18.3	10.1	3.8	30.6	5.7	15.9	15.2	16.9	5.8	3.2	6.8	25.2	13.8	52.7	27.8	12.5	10.8	103.0	104.0	9.7	25.6	123.9	14.6	13.6	36.2	5.8	18.2	4.1	14.5	69.2	3.9	60.9	23.7	11.8	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	13.6	12.5	12.8	11.9	18.3	15.9	15.2	13.8	14.6	18.2	11.8	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281280-36387967	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 1343.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Nuclear bodies,Plasma membrane,Actin filaments,Cytosol"		No	No		410000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments"	"Nuclear bodies, Cytosol"	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	295.9	95.5	42.3	181.1	42.1	245.9	231.5	40.6	54.7	181.2	65.5	192.6	107.0	356.4	39.3	153.8	182.2	134.5	161.1	50.8	39.4	140.7	101.6	286.2	161.7	52.7	51.7	121.1	160.3	55.0	52.6	166.5	48.1	131.8	89.8	9.7	177.2	98.4	84.0	160.6	163.5	174.1	48.8	232.5	135.8	38.2	52.1	125.1	141.2	46.3	104.1	168.8	166.8	48.2	612.2	277.0	86.2	74.2	156.8	195.1	437.3	398.4	507.5	554.6	413.2	302.1	170.3	156.9	230.1	666.1	265.0	412.7	125.2	779.4	559.6	356.1	120.9	302.6	294.3	259.9	481.1	346.9	463.8	233.0	234.7	751.9	626.4	540.3	461.8	113.2	67.3	205.8	448.9	161.9	124.4	204.0	51.7	171.1	169.2	233.3	267.3	146.7	314.5	581.5	129.6	53.0	559.7	217.0	251.6	218.5	162.4	177.1	1343.7	1222.6	370.3	237.5	731.5	135.2	114.7	129.0	463.2	172.3	363.1	72.6	25.2	64.7	32.4	19.8	28.4	13.4	23.5	26.4	17.2	11.9	18.3	20.4	41.2	9.0	26.5	8.0	26.3	54.5	42.3	42.1	40.6	54.7	50.8	39.4	52.7	51.7	48.1	48.8	52.1	48.2	303.9	118.6	87.1	12.7	108.4	144.0	182.4	123.1	72.8	2.6	90.5	89.4	62.6	80.1	89.7	92.0	2.1	87.0	151.7	359.8	7.9	309.4	35.8	89.7	121.6	258.7	73.8	51.9	42.5	245.8	193.1	82.9	123.8	194.7	93.1	117.1	132.8	102.8	100.4	82.4	6.7	131.0	59.0	119.6	124.2	37.4	68.0	168.8	85.4	61.8	196.6	11.9	137.0	7.5	33.3	344.6	186.8	211.4	125.9	184.4	159.8	27.5	51.5	5.3	203.8	39.9	275.2	6.9	10.4	133.6	135.1	46.4	213.2	141.3	139.5	134.3
MYO15A	"DFNB3, MYO15"	ENSG00000091536	"Myosin XVA"	Q9UKN7	17	18108706-18179802	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"pituitary gland: 62.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 69.9;Late spermatids: 53.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078501	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA078501: AB_2732383"	"unprognostic (2.48e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.33e-1)"	"unprognostic (8.32e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.18e-3)"	"unprognostic (5.69e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-2)"	0.5	0.4	0.5	0.3	0.4	0.1	0.6	0.5	1.5	1.3	0.0	0.7	0.3	1.0	1.5	0.3	1.4	0.2	0.6	0.0	0.6	0.6	1.9	0.9	0.1	1.8	0.5	2.2	0.5	0.8	62.9	0.1	2.1	0.9	0.3	0.3	0.6	0.9	0.4	0.3	0.6	0.2	0.5	0.5	0.6	7.2	1.4	0.8	0.9	0.0	0.2	0.7	0.8	0.4	0.0	0.0	0.4	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.5	0.4	0.5	1.5	0.0	0.6	1.8	0.5	2.1	0.5	1.4	0.4	0.3	0.0	1.1	0.7	0.8	1.5	2.1	0.2	1.2	2.9	0.9	0.6	4.0	1.5	0.1	0.0	0.0	0.5	0.3	0.7	0.0	0.8	69.9	0.8	0.9	1.0	4.2	0.0	8.5	0.9	0.3	1.4	0.5	1.2	6.3	1.3	0.4	1.7	0.6	10.1	4.5	0.5	0.0	0.8	1.4	53.6	1.2	0.8	3.6	1.0	1.3	2.6	2.1	1.5	0.9	0.6	0.1	1.2	0.1	1.9	0.4	0.3	0.2	2.5	0.0	4.6	1.1	9.2	13.4	0.4	1.3	0.7	0.6	0.7	0.8	1.0
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128246-77215241	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 41.9;choroid plexus: 53.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Cytotrophoblasts: 42.3;Hofbauer cells: 30.1;Kupffer cells: 17.8;Rod photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.6;intermediate monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.8;CACO-2: 9.0;RH-30: 19.5;RPMI-8226: 13.8;SK-BR-3: 10.5;U-937: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB034059	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB034059: AB_2148626"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.2	41.9	2.5	3.0	2.9	1.0	3.1	2.2	2.7	1.9	53.2	2.8	2.2	1.5	1.2	1.0	2.7	2.8	2.5	4.0	8.6	4.3	23.3	2.3	2.9	5.0	8.3	5.2	5.4	0.5	19.1	16.0	8.4	2.4	1.2	27.4	1.5	0.8	1.4	0.8	2.8	2.2	3.5	15.8	2.2	24.5	5.1	1.4	2.0	0.7	1.1	2.0	1.6	4.4	0.0	1.3	0.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	9.0	2.0	0.0	2.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	5.7	0.2	0.4	0.0	0.1	0.0	0.0	0.5	0.0	3.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.3	0.0	19.5	13.8	0.0	0.3	2.9	0.9	0.1	10.5	0.1	2.2	1.3	1.3	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	2.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	2.5	2.9	2.2	2.7	4.0	8.6	5.0	8.3	8.4	3.5	5.1	4.4	1.7	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	14.2	0.5	0.5	4.4	4.3	0.0	0.0	47.9	42.3	0.3	0.2	0.0	0.6	1.9	0.1	0.5	2.2	1.2	0.0	0.7	1.7	10.5	1.4	5.6	0.3	0.0	0.8	16.4	16.1	30.1	0.0	0.8	0.7	0.0	17.8	0.9	6.4	3.1	7.3	0.0	6.5	0.8	17.0	0.0	3.0	0.1	0.7	0.2	0.4	0.1	0.1	1.7	2.7	0.1	31.4	0.0	5.2	0.3	0.4	0.6	0.1	0.3	16.1	1.4	3.2	0.6	0.2
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
OSBPL2	"DFNA67, KIAA0772, ORP-2"	ENSG00000130703	"Oxysterol binding protein like 2"	Q9H1P3	20	62231922-62296213	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 94.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 94.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041127, HPA042659"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA041127: AB_10962008, HPA042659: AB_10960683"	"unprognostic (1.00e-3)"	"unprognostic (7.20e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.20e-5)"	"unprognostic (3.86e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.32e-2)"	14.6	15.2	21.1	13.4	21.2	32.9	18.9	38.9	21.4	21.9	20.0	24.3	22.8	14.0	15.8	40.7	15.6	20.0	25.4	16.6	20.3	20.8	18.0	16.2	14.3	23.7	24.0	15.8	39.7	26.4	26.4	13.7	22.3	19.8	22.7	14.5	24.9	18.8	18.0	43.5	21.6	17.4	19.4	24.9	27.9	14.9	29.8	17.2	21.9	11.9	20.4	23.1	29.8	19.4	23.9	17.0	19.6	18.3	19.4	19.1	18.5	14.2	27.9	46.6	32.1	61.0	24.1	11.5	37.1	28.4	41.8	40.7	18.9	42.4	25.7	13.7	17.7	30.6	21.5	31.2	19.0	11.8	26.6	17.7	61.0	20.8	23.3	22.1	19.1	29.4	20.3	21.2	13.5	19.4	17.2	19.8	6.4	43.5	15.0	15.9	23.5	15.3	23.6	48.2	25.6	16.7	25.7	48.2	24.3	25.9	32.1	21.0	13.2	23.2	17.0	24.7	17.3	24.5	37.4	17.5	25.7	8.4	14.9	16.1	9.2	34.5	13.0	11.7	11.4	13.7	10.5	13.7	9.9	10.9	9.5	11.4	94.6	16.8	9.9	7.1	17.5	10.9	21.1	21.2	38.9	21.4	16.6	20.3	23.7	24.0	22.3	19.4	29.8	19.4	27.1	16.0	18.3	17.3	16.5	20.1	24.8	24.4	14.2	18.9	24.7	16.6	61.2	15.7	28.2	11.0	6.2	13.4	21.6	44.5	31.3	22.7	33.0	22.6	12.0	18.1	16.3	24.2	13.9	20.1	14.8	17.8	42.8	34.2	10.8	19.2	12.8	14.1	12.3	18.5	21.7	29.6	22.4	11.1	8.0	17.4	17.4	14.3	8.8	10.3	16.8	18.2	27.8	9.0	15.5	39.8	37.0	13.2	21.9	38.8	30.2	14.1	34.3	15.9	13.1	14.8	13.1	22.8	11.1	25.2	27.8	37.1	18.5	12.0	25.7	58.7
OTOA	"CT108, DFNB22"	ENSG00000155719	Otoancorin	Q7RTW8	16	21663968-21761935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 1.8;testis: 4.0"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 111.8;Kupffer cells: 60.5;Late spermatids: 18.7;Macrophages: 34.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041405	Enhanced				"Secreted in other tissues"	NA	NA		51000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 4: Macrophages - Innate immune response"			"HPA041405: AB_10796344"	"unprognostic (7.96e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.71e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.18e-2)"	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	4.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	8.4	0.0	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.0	1.8	0.0	0.4	0.1	0.3	0.0	0.2	11.6	0.3	0.2	1.0	1.2	0.0	2.6	0.4	0.8	0.3	0.0	0.5	5.7	0.1	0.7	0.4	111.8	0.0	1.8	0.1	0.0	60.5	3.7	18.7	0.3	34.4	1.8	0.0	1.9	0.0	0.0	0.5	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.7	0.0	0.0	6.6	0.2	0.7	9.4	7.4	0.0	0.1	0.5	0.2	0.1	0.2	0.2
OTOF	"DFNB6, DFNB9, FER1L2"	ENSG00000115155	Otoferlin	Q9HC10	2	26457203-26558756	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"bone marrow: 6.4;brain: 23.1"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 4.0;Skeletal myocytes: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HDLM-2: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012410	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA012410: AB_1854836"	"unprognostic (4.01e-3)"	"unprognostic (7.85e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.20e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.85e-14)"	"unprognostic (1.33e-2)"	"unprognostic (5.19e-1)"	"unprognostic (9.65e-2)"	"unprognostic (8.96e-5)"	0.2	0.5	23.1	0.3	16.3	6.4	0.2	0.2	13.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.3	0.1	4.1	3.3	0.0	0.0	0.2	0.1	5.2	2.8	0.0	0.1	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.1	4.2	0.5	0.2	1.1	3.0	0.9	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.1	16.3	0.2	13.1	4.1	3.3	5.2	2.8	4.0	4.2	3.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.8	0.3	0.0	0.0	0.1	0.5	0.4	0.0	0.0
OTOG	"FLJ46346, mlemp, OTGN"	ENSG00000188162	Otogelin	Q6ZRI0	11	17547259-17647150	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"pituitary gland: 1.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 11.9;Late spermatids: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"CACO-2: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.85e-6)"	"unprognostic (1.89e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.14e-5)"	"unprognostic (1.78e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.57e-2)"		"unprognostic (4.72e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.48e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.9;kidney: 5.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.5	0.0	0.7	0.0	0.1	0.0	1.0	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.1	1.9	0.3	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622388	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;epididymis: 21.8;prostate: 14.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.6;Endometrial ciliated cells: 2.6;Fibroblasts: 8.3;Gastric mucus-secreting cells: 1.1;Peritubular cells: 3.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Group enriched"	"Detected in many"	7	"amygdala: 9.2;cerebral cortex: 11.3;hippocampal formation: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 5.1;T-47d: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	1.1	0.1	9.2	0.6	0.4	0.1	0.2	0.3	11.3	0.7	0.0	2.4	1.1	0.2	21.8	7.2	9.3	0.1	0.0	10.1	1.5	2.5	0.4	4.9	1.9	0.1	0.2	0.3	0.5	0.7	1.3	0.4	0.1	14.1	0.3	0.0	0.1	9.0	0.0	0.2	4.3	0.1	0.0	3.2	1.7	1.5	1.0	0.4	0.2	0.0	0.8	1.0	1.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	5.1	0.1	0.3	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.9	0.0	0.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.4	0.3	11.3	10.1	1.5	0.1	0.2	0.1	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.1	0.1	0.0	0.0	0.1	0.0	0.1	8.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1
PCDH15	"CDHR15, DFNB23, USH1F"	ENSG00000150275	"Protocadherin related 15"	Q96QU1	10	53802771-55627942	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing"		"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 19.0;brain: 21.2;retina: 61.7"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocyte precursor cells: 2965.2"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.1;U-266/70: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074437		Supported			"Intracellular and membrane"	NA	NA		22000		"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA074437: "	"unprognostic (1.38e-1)"	"unprognostic (3.39e-1)"		"unprognostic (8.15e-5)"	"unprognostic (3.07e-3)"	"unprognostic (2.79e-1)"		"unprognostic (9.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-3)"		"unprognostic (1.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.66e-3)"	0.2	19.0	13.4	0.3	9.5	0.1	0.0	3.1	10.3	0.2	0.0	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.5	16.6	19.6	8.0	0.0	2.5	0.4	13.8	13.7	0.0	0.0	0.5	4.7	0.2	12.6	0.2	0.0	61.7	0.1	0.0	0.0	0.1	0.2	0.0	9.7	0.7	0.3	3.3	21.2	0.1	0.0	0.0	0.5	0.5	0.0	6.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.1	0.0	0.0	3.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	9.5	3.1	10.3	16.6	19.6	13.8	13.7	12.6	9.7	21.2	6.2	0.0	0.0	0.0	14.4	0.0	0.3	0.0	0.0	0.0	5.1	0.6	0.0	4.8	0.0	0.0	0.0	87.6	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	0.3	0.0	0.0	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	216.2	0.1	0.0	0.0	0.0	7.5	0.0	0.1	0.0	3.7	0.0	4.4	0.0	2965.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	92.8	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32428131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 68.9;heart muscle: 58.5"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 1071.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.4;fHDF/TERT166: 148.3;hTERT-RPE1: 44.9;U-251 MG: 77.9;WM-115: 105.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.4	1.8	19.2	2.5	43.0	0.0	4.3	21.4	39.9	0.7	0.0	3.0	1.4	2.4	6.0	6.4	10.5	1.5	58.5	18.9	24.2	4.2	0.1	4.9	0.6	29.4	27.9	3.8	2.6	0.3	1.3	3.2	27.7	2.0	1.8	7.4	1.8	3.2	0.6	0.4	3.3	5.0	16.4	0.6	4.0	3.8	28.6	1.6	3.1	4.0	0.1	9.8	1.4	68.9	0.3	5.8	15.5	0.0	0.6	0.4	0.2	44.4	18.3	20.8	17.1	0.0	0.0	0.0	0.2	148.3	0.0	1.2	0.0	0.0	27.1	0.0	0.0	1.3	1.4	0.0	0.1	0.0	31.9	1.9	0.0	4.3	0.2	44.9	7.1	0.0	0.1	0.1	1.7	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	22.5	0.0	6.8	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	22.8	8.6	0.4	77.9	0.4	0.0	0.0	2.4	0.5	105.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	43.0	21.4	39.9	18.9	24.2	29.4	27.9	27.7	16.4	28.6	68.9	1.2	0.0	0.0	7.5	0.1	0.0	0.7	0.1	1.2	69.5	2.8	17.1	136.0	0.0	0.7	1.8	52.1	0.0	0.1	0.0	0.0	4.8	53.4	0.2	0.1	3.9	0.0	0.0	70.8	0.4	0.0	8.7	0.0	0.4	8.8	0.2	0.0	0.0	0.1	3.3	169.2	0.0	59.0	0.0	0.2	50.3	0.3	0.5	0.0	15.9	0.0	0.9	0.0	196.6	1071.4	0.2	0.0	0.4	0.1	0.2	0.0	0.0	2.2	4.7	0.0	0.9	9.4	1.3	1.2	0.2	0.0	0.0	0.1	1.2	0.0	0.0
PDZD7	"bA108L7.8, DFNB57, FLJ23209, PDZK7"	ENSG00000186862	"PDZ domain containing 7"	Q9H5P4	10	101007679-101032295	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 21.5;intestine: 20.0;pituitary gland: 6.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 15.9;Cone photoreceptor cells: 22.9;Excitatory neurons: 32.3;Inhibitory neurons: 16.5;Proximal enterocytes: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 7.5;SCLC-21H: 11.7;THP-1: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074542			Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA074542: "	"unprognostic (1.46e-1)"	"unprognostic (2.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-1)"	1.5	1.3	5.8	1.0	8.0	1.3	0.5	10.2	15.4	0.7	0.7	0.4	12.8	1.4	0.9	0.3	0.4	1.9	0.6	5.7	4.5	1.5	0.1	1.0	0.9	21.5	7.7	0.6	0.9	1.1	6.0	1.0	21.0	0.7	0.2	2.3	1.1	0.5	0.9	2.4	20.0	1.0	2.7	1.6	1.0	1.2	8.8	0.7	1.2	0.2	0.1	0.4	0.8	9.9	7.5	0.9	0.5	0.7	0.9	0.1	2.3	1.2	0.6	0.0	0.3	1.5	1.7	3.7	3.5	0.3	1.0	2.2	0.2	0.7	0.0	1.0	2.5	0.2	3.8	2.3	0.6	0.5	3.1	0.3	0.1	0.2	0.1	4.2	0.2	3.3	0.6	0.7	0.1	1.8	0.5	1.2	0.6	1.5	2.4	1.6	1.0	0.4	1.8	0.6	11.7	5.4	0.8	0.3	1.2	1.0	2.4	18.2	0.5	1.1	2.4	1.4	1.0	1.5	0.1	0.2	6.4	1.2	0.6	0.6	0.4	0.5	0.3	0.4	0.3	0.3	0.2	0.4	0.1	0.3	0.4	0.2	1.6	0.8	0.3	0.1	0.1	0.3	5.8	8.0	10.2	15.4	5.7	4.5	21.5	7.7	21.0	2.7	8.8	9.9	0.8	0.0	0.0	1.3	0.1	0.5	0.5	0.2	0.0	15.9	0.5	0.9	1.4	2.8	0.2	1.8	22.9	0.2	0.1	0.2	1.9	0.7	1.7	2.1	0.3	0.7	0.0	0.0	32.3	0.4	5.2	0.8	1.1	0.3	0.0	1.6	0.7	0.0	2.1	1.7	16.5	1.5	0.0	1.3	2.7	2.6	0.3	1.0	0.0	5.6	0.3	0.9	1.0	0.5	6.9	1.3	1.2	1.2	0.3	0.4	56.7	1.6	1.3	8.3	0.0	1.4	1.7	2.9	3.7	0.2	0.4	1.9	0.8	0.1	1.0	0.2
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178462102	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.1;Distal tubular cells: 3.9;Granulosa cells: 6.1;Theca cells: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.8"	"Cell line enhanced"	"Detected in many"		"SuSa: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042621			Approved	Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	3.0	1.8	6.9	1.3	7.2	1.4	4.8	6.9	10.7	2.7	6.9	1.9	1.2	3.9	7.3	1.2	2.8	2.9	1.4	7.0	7.0	3.2	2.8	1.5	1.9	7.6	7.3	7.1	1.3	1.1	4.1	1.2	7.5	2.8	1.2	6.4	2.7	3.0	3.5	4.2	1.4	2.0	7.3	1.4	1.2	20.7	7.1	1.2	2.5	0.9	1.7	1.9	1.4	7.7	0.2	1.8	2.3	1.9	3.0	3.1	1.2	1.5	1.4	1.2	2.0	0.7	3.1	2.1	1.5	0.9	1.0	0.9	1.7	1.0	0.9	0.7	0.6	0.7	2.9	0.4	3.0	0.6	0.2	3.2	2.2	1.4	3.2	3.8	1.5	4.1	0.4	1.3	1.5	0.5	2.1	1.3	2.8	0.2	0.8	2.7	1.7	1.3	2.0	1.0	1.6	1.3	0.5	0.3	0.6	6.8	0.7	0.7	1.0	1.5	0.6	0.4	0.1	4.3	2.8	0.7	0.7	1.1	0.6	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.0	0.5	0.5	0.3	0.4	0.2	0.0	2.8	0.0	0.0	6.9	7.2	6.9	10.7	7.0	7.0	7.6	7.3	7.5	7.3	7.1	7.7	1.6	6.4	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	2.4	0.0	0.0	1.8	1.8	0.0	1.1	0.5	0.0	3.9	1.4	0.0	1.8	2.6	0.4	0.0	0.0	0.0	0.9	0.5	1.4	0.0	1.6	0.0	6.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596393-142713664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 315.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 471.4;Intestinal goblet cells: 147.9;Paneth cells: 200.5;Proximal enterocytes: 335.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 36.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.6;NK-cells: 3.2;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A-431: 90.0;BEWO: 112.3;OE19: 166.4;RPTEC TERT1: 143.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055744, HPA061936"	Enhanced					NA	NA		56000000	"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055744: AB_2682903, HPA061936: "	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	1.6	3.9	0.8	18.8	1.3	7.4	5.7	2.7	2.2	10.1	11.7	144.2	191.6	3.3	3.1	9.6	7.7	27.7	1.2	1.1	1.4	26.7	27.5	14.8	1.7	3.3	0.3	0.9	12.2	15.7	6.2	1.5	3.2	3.1	139.1	24.9	9.1	1.9	0.9	3.6	315.6	4.3	0.3	0.9	45.8	7.5	0.4	5.9	7.7	0.9	2.9	19.6	3.7	1.4	90.0	69.2	4.8	10.4	0.7	0.0	112.3	1.7	2.3	9.4	20.1	31.7	68.8	15.2	35.8	0.1	31.9	18.9	18.8	28.7	20.0	5.5	27.0	27.2	10.2	11.4	0.9	13.0	1.7	0.1	4.7	17.8	11.4	14.8	4.5	16.4	11.8	1.7	1.1	21.0	21.4	7.0	18.9	166.4	25.9	8.7	20.3	12.7	143.6	81.7	24.1	9.7	10.0	7.0	7.8	13.3	55.6	2.2	1.2	1.1	11.3	3.5	21.3	12.7	12.6	18.1	3.2	12.8	3.5	1.9	0.2	2.6	1.5	0.2	2.0	0.3	1.8	2.0	0.4	0.3	2.2	2.6	1.8	3.2	0.2	0.5	1.3	1.0	0.8	1.3	2.7	2.2	1.1	1.4	3.3	0.3	3.2	0.3	0.4	1.4	0.6	54.5	38.0	1.3	1.6	2.9	4.1	23.2	2.8	3.4	9.7	4.2	3.1	54.3	46.8	44.1	16.7	5.8	0.7	471.4	21.5	21.8	64.3	22.2	1.8	0.7	53.9	5.9	18.7	34.0	1.9	1.1	50.0	26.8	8.9	32.3	1.1	31.5	0.6	5.0	25.2	147.9	24.4	1.6	1.0	20.5	1.2	1.4	1.8	5.6	0.8	2.8	0.0	4.0	3.1	70.2	200.5	0.0	2.8	6.8	335.1	40.6	42.2	13.4	0.0	1.2	1.9	4.6	4.1	7.6	3.3	1.4	1.8	1.3	85.2	20.7
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"		X	83508290-83512127	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	7	"brain: 11.9"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 11.0"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	99	"AF22: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA062295: AB_2732681"					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.0	0.0	2.3	0.0	11.9	0.0	0.0	2.6	4.5	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	2.5	1.6	0.0	0.0	0.0	2.9	5.5	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	11.9	2.6	4.5	1.5	2.5	2.9	5.5	2.5	2.6	3.4	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU4F3	"BRN3C, DFNA15, DFNA42, DFNA52"	ENSG00000091010	"POU class 4 homeobox 3"	Q15319	5	146338839-146341728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038215	Uncertain		Supported	Nucleoplasm		NA	NA							Nucleoplasm		"HPA038215: AB_10697245"	"unprognostic (8.41e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.12e-1)"		"unprognostic (1.03e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (7.82e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIP5K2	"CFAP160, DFNB100, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	15.7	19.1	6.8	22.0	7.9	51.6	25.1	18.9	13.9	22.2	5.8	28.1	18.3	20.6	21.2	17.1	14.5	20.4	19.5	6.7	8.9	20.3	29.2	16.2	25.5	15.4	11.9	26.1	26.7	23.0	18.1	16.7	15.1	16.3	25.5	19.2	17.1	15.4	4.2	17.2	16.5	18.4	6.1	23.9	22.5	15.1	7.3	27.9	23.3	7.7	24.5	17.8	13.9	10.7	27.4	25.3	50.8	65.2	40.8	53.4	47.8	63.5	39.3	34.2	47.6	20.9	48.3	67.6	56.2	60.9	52.7	16.5	43.9	33.2	57.5	53.7	23.5	84.7	44.3	33.4	29.0	72.1	70.4	34.5	23.4	52.0	46.1	31.2	40.0	42.5	84.9	57.0	53.1	21.3	60.9	44.6	55.4	12.7	64.4	58.6	46.7	89.3	36.8	31.5	29.6	40.1	43.5	39.9	40.7	34.0	33.5	48.9	42.7	55.8	25.7	56.0	45.1	38.1	87.3	91.3	31.5	116.0	51.2	41.7	21.5	39.6	13.0	22.9	15.8	19.5	12.6	14.2	25.6	16.1	16.1	17.0	19.7	17.8	32.4	15.5	12.3	11.1	6.8	7.9	18.9	13.9	6.7	8.9	15.4	11.9	15.1	6.1	7.3	10.7	35.8	48.1	23.1	49.3	39.3	13.6	12.8	13.7	31.9	38.5	26.1	26.4	48.9	18.6	29.6	16.5	45.9	12.7	35.7	29.7	5.9	11.6	5.6	25.4	44.7	28.7	16.3	70.7	88.4	17.0	19.2	33.0	33.6	30.6	43.6	49.2	14.6	20.6	30.6	16.8	160.3	24.2	16.2	39.5	22.4	6.7	29.5	43.3	12.4	49.6	47.5	14.5	27.8	62.8	67.0	16.9	19.1	23.7	56.6	12.1	13.3	22.6	25.1	25.2	6.6	30.3	28.1	39.7	21.6	31.6	15.8	26.0	31.6	38.7	30.1	12.6
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628428-107651993	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043760, HPA051269"	Uncertain		Approved	Vesicles		NA	NA		320000	"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA043760: AB_2678656, HPA051269: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	22.9	28.0	33.7	30.2	35.0	58.0	21.0	32.4	36.4	20.0	59.3	19.0	11.0	23.7	14.8	13.7	25.9	13.9	22.2	33.7	39.6	27.6	51.5	21.5	42.7	35.4	39.1	30.2	21.7	27.2	23.2	14.6	37.6	21.3	17.9	30.2	16.3	17.4	49.1	12.3	16.7	29.5	34.2	26.2	15.5	13.4	35.2	52.0	44.1	37.9	45.7	23.6	15.2	34.4	93.5	128.9	56.4	69.9	32.7	26.5	18.6	253.2	55.8	146.0	122.6	55.5	36.6	156.9	111.7	94.9	104.1	36.6	176.0	53.8	148.3	79.9	150.9	84.2	140.0	100.3	28.8	153.1	55.6	28.2	30.6	90.2	56.2	96.7	52.3	108.2	137.4	183.5	69.0	51.0	101.2	113.6	213.5	77.2	141.4	117.6	96.3	125.4	60.7	54.2	96.2	52.5	131.5	77.6	57.3	106.4	36.0	61.7	31.2	93.2	45.0	108.3	109.1	61.8	115.1	172.7	50.1	163.6	61.6	8.8	8.9	22.6	26.0	14.3	30.8	29.3	31.7	32.2	11.4	31.0	36.1	30.7	4.7	28.5	15.7	16.3	35.5	21.1	33.7	35.0	32.4	36.4	33.7	39.6	35.4	39.1	37.6	34.2	35.2	34.4	21.0	6.4	10.0	4.6	44.2	31.1	18.4	13.2	12.0	28.4	8.3	9.4	12.1	15.7	12.6	16.5	4.2	8.8	29.3	3.0	25.4	18.3	1.2	11.5	13.3	18.1	16.2	52.2	4.8	20.2	11.5	22.2	10.2	5.7	26.6	13.2	14.6	57.5	35.3	15.2	10.0	6.5	6.1	18.6	34.8	3.9	14.0	16.8	26.6	6.5	24.9	20.0	27.8	3.5	4.8	19.1	3.7	17.0	35.7	16.2	1.5	29.4	27.1	14.1	0.0	18.1	30.7	3.6	10.9	10.8	22.3	1.8	45.0	19.7	8.0	9.7
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase receptor type Q"		12	80402178-80680273	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.1;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Club cells: 4.4;Early spermatids: 10.9;Excitatory neurons: 11.2;Late spermatids: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;BJ: 3.9;HBF TERT88: 2.6;RH-30: 2.9;RT4: 3.4;SiHa: 1.9;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	3.2	0.0	0.3	0.0	2.0	0.0	0.4	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.1	1.6	0.2	1.1	0.2	0.4	7.1	0.0	2.3	0.9	1.0	0.7	0.3	0.3	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.0	0.1	2.7	0.3	0.2	2.9	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	3.9	0.8	1.2	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.4	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.7	0.2	0.4	1.0	0.7	0.6	0.8	0.3	0.0	0.0	16.0	1.1	2.0	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.0	3.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.5	1.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296712	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 155.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		38000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	40.3	155.0	38.0	17.4	57.7	12.0	16.4	50.0	42.7	32.1	32.8	15.2	6.8	28.8	12.9	27.4	19.7	27.2	41.0	35.1	44.7	50.2	68.5	48.8	11.4	52.7	48.2	52.8	52.7	33.2	7.6	35.3	54.3	25.4	11.1	19.2	20.8	26.0	82.1	11.9	7.4	35.0	45.1	26.6	15.0	33.7	47.7	14.3	45.7	59.7	14.6	27.1	10.1	77.6	69.6	35.3	137.3	54.8	78.8	87.4	79.3	85.8	47.6	54.3	59.2	99.7	115.4	0.1	127.4	104.7	84.9	61.5	77.3	80.4	80.5	41.9	44.2	51.5	107.7	74.1	73.6	19.0	33.2	89.7	45.6	68.0	120.1	89.3	149.8	11.1	73.5	29.5	127.0	120.0	11.0	15.6	44.0	4.0	58.4	31.2	96.8	30.1	68.1	33.5	37.2	40.5	148.5	65.9	52.7	102.5	85.0	29.9	92.6	89.5	66.8	43.9	67.4	9.5	17.3	65.9	34.2	11.3	210.9	29.5	14.8	22.0	11.6	12.5	15.5	11.5	10.2	8.8	12.8	8.3	6.8	5.8	2.0	17.6	9.9	10.3	22.0	8.4	38.0	57.7	50.0	42.7	35.1	44.7	52.7	48.2	54.3	45.1	47.7	77.6	248.8	484.0	98.8	53.5	30.0	56.1	51.8	124.6	56.9	85.9	47.4	45.7	159.3	70.1	77.9	75.4	43.8	122.1	21.6	17.7	109.5	128.1	15.5	109.1	117.2	289.2	22.2	104.8	27.1	423.4	189.8	88.4	19.9	135.3	67.2	132.0	319.2	260.1	85.1	101.0	57.6	7.3	61.1	103.2	59.9	43.6	275.2	71.6	72.9	42.2	135.4	77.0	36.0	68.3	229.4	134.3	22.1	266.7	36.1	65.9	0.1	236.9	52.2	94.8	124.9	74.0	143.8	73.9	257.4	52.8	40.5	227.3	29.2	229.9	11.8	45.9
REST	"DFNA27, NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966808	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	6.9	5.5	5.7	9.4	6.5	24.8	9.8	6.3	7.5	8.8	9.4	6.9	6.4	9.3	8.9	8.2	7.8	7.9	7.6	5.0	5.2	10.9	11.5	8.0	13.4	8.0	6.6	11.2	7.7	13.8	0.5	9.9	7.8	10.0	7.0	7.5	7.8	8.1	5.2	8.9	6.3	8.0	6.6	10.7	8.2	12.3	6.8	18.1	10.9	6.5	13.6	8.7	2.1	7.4	10.8	13.0	17.4	18.2	13.2	16.0	22.7	15.6	13.8	16.0	14.7	11.5	16.5	24.5	23.5	16.8	10.7	9.8	13.2	16.3	24.4	12.6	8.1	22.0	9.4	12.5	16.2	29.0	13.5	16.5	14.6	15.1	16.0	20.5	20.1	19.0	14.3	26.3	19.0	17.3	31.5	21.3	15.2	12.3	8.9	30.0	14.5	8.1	19.0	18.3	0.3	8.1	17.8	18.8	14.6	24.8	19.3	20.3	28.7	20.4	18.1	12.4	14.2	10.8	7.8	15.1	13.2	16.7	10.8	7.4	2.5	7.2	6.2	3.9	6.2	11.6	6.9	5.9	5.2	21.1	10.8	4.4	2.8	6.1	7.9	6.0	9.4	2.5	5.7	6.5	6.3	7.5	5.0	5.2	8.0	6.6	7.8	6.6	6.8	7.4	38.1	70.5	60.2	18.6	51.1	57.1	51.9	33.3	99.6	1.6	42.6	35.2	50.2	42.9	43.3	29.5	81.3	58.0	65.2	21.4	23.5	58.4	9.7	67.3	64.3	50.5	3.6	54.7	0.1	38.2	57.1	40.8	23.9	63.4	51.4	56.3	47.2	31.0	32.2	0.0	0.2	23.5	44.7	36.2	37.9	11.9	39.4	44.0	21.4	12.2	78.0	45.1	71.1	11.1	21.1	45.8	29.0	36.9	44.3	44.3	22.1	24.4	43.3	36.1	32.9	56.5	56.0	58.3	53.8	55.0	45.7	66.4	66.6	62.3	26.1	48.7
RIPOR2	"C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP"	ENSG00000111913	"RHO family interacting cell polarization regulator 2"	Q9Y4F9	6	24804282-25042170	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Differentiation, Hearing, Myogenesis"	"Developmental protein, Signal transduction inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 57.4;dendritic cells: 98.4;Respiratory ciliated cells: 83.1;Syncytiotrophoblasts: 82.8;T-cells: 38.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 951.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 951.9"	"Cell line enhanced"	"Detected in many"		"AF22: 30.9;Daudi: 73.5;fHDF/TERT166: 73.2;U-266/70: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (4.05e-3)"	"unprognostic (1.34e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.89e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	13.1	3.7	15.9	49.1	22.4	27.6	6.1	0.4	16.7	13.5	2.5	3.7	2.7	46.3	2.6	3.2	14.8	8.6	3.1	14.0	9.1	3.0	4.3	20.7	82.6	4.5	9.5	2.7	2.5	0.9	13.0	6.0	3.2	6.1	3.8	3.7	8.2	4.5	19.5	5.2	17.5	17.7	4.6	55.9	6.7	6.4	9.2	41.0	2.9	7.6	71.0	10.2	7.4	4.9	1.1	0.1	30.9	0.6	0.3	0.2	11.3	8.8	15.5	3.7	5.4	0.4	0.5	73.5	2.0	73.2	0.5	0.9	0.0	0.0	0.7	7.3	0.4	17.8	1.2	0.3	0.6	0.4	1.3	3.2	0.3	0.0	0.4	0.2	0.0	3.2	1.0	12.2	0.2	0.2	17.0	0.8	2.3	1.2	2.1	18.5	3.0	0.7	0.1	0.4	1.5	0.3	0.6	0.3	5.7	10.3	0.3	0.5	0.3	0.7	3.3	0.8	0.9	25.4	0.6	2.4	0.8	1.0	5.1	414.0	100.8	334.5	128.6	127.3	134.8	188.3	131.8	136.6	68.7	176.3	171.6	136.8	951.9	125.7	173.8	57.7	124.9	168.1	15.9	22.4	0.4	16.7	14.0	9.1	4.5	9.5	3.2	4.6	9.2	4.9	7.3	3.2	14.6	0.0	57.4	0.0	0.0	0.0	0.0	0.0	3.3	1.7	0.0	0.0	18.6	5.5	0.0	4.1	98.4	0.0	1.9	0.1	0.0	16.4	10.5	2.8	0.0	0.0	0.0	0.2	1.9	2.7	0.0	10.7	12.6	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	15.6	0.0	0.0	3.1	83.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	82.8	38.0	1.7	0.0	0.0
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774017-64181498	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Astrocytes: 81.0;Inhibitory neurons: 69.7;Microglial cells: 36.5;Oligodendrocytes: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 40.5;ASC TERT1: 50.3;CACO-2: 36.8;HHSteC: 38.3;HSkMC: 41.6;NTERA-2: 43.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		7700000	"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	4.4	1.1	0.6	2.2	1.4	0.4	3.7	3.0	0.8	7.5	4.6	4.5	2.2	7.1	1.4	5.2	2.5	5.2	7.5	0.7	0.6	2.3	0.5	7.0	1.2	0.7	0.9	8.3	5.5	26.9	0.5	3.1	0.5	5.4	4.0	1.5	1.2	6.4	2.3	2.3	1.7	7.7	0.3	3.2	6.4	1.5	1.2	2.5	1.4	1.6	1.1	4.2	2.3	1.1	15.5	12.2	5.9	0.8	40.5	50.3	4.0	2.9	8.3	1.6	4.3	36.8	4.9	0.3	6.6	7.2	2.9	3.2	0.1	2.9	1.1	0.0	3.7	0.0	1.6	0.5	38.3	0.0	0.0	41.6	10.9	21.7	25.2	8.4	0.7	0.5	0.0	0.3	11.0	0.2	0.2	0.1	43.0	11.3	6.1	0.2	0.2	9.8	8.7	0.3	3.4	13.6	0.8	0.2	6.4	19.9	0.1	0.0	8.4	3.3	5.7	23.0	6.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.6	1.4	3.0	0.8	0.7	0.6	0.7	0.9	0.5	0.3	1.2	1.1	1.1	51.3	10.5	81.0	1.8	3.8	2.2	0.5	29.0	4.7	3.0	2.0	11.4	1.5	1.3	1.8	0.0	0.2	0.1	1.3	0.0	5.6	9.6	1.2	9.2	1.8	21.5	0.0	11.6	15.2	1.0	14.5	16.8	1.9	0.0	1.1	0.7	0.0	7.6	0.0	69.7	2.2	2.0	0.6	4.9	8.1	27.7	0.5	3.6	36.5	0.0	5.3	0.0	3.5	109.9	15.3	0.8	14.7	0.1	1.4	0.0	3.4	0.8	0.3	6.6	6.8	8.5	1.4	1.8	11.5	4.5	0.3	0.2	0.3	3.3	0.8
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 45.0;T-cells: 12.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	7.7	2.5	1.9	6.4	1.8	1.2	5.5	1.7	1.8	10.4	1.9	4.8	1.8	8.3	2.7	3.3	8.4	6.2	6.6	1.6	2.0	3.1	5.6	13.7	10.9	2.8	1.9	5.6	2.9	2.5	3.0	18.5	2.2	6.9	2.4	1.2	4.1	2.3	0.8	5.4	4.8	4.2	2.0	1.9	4.3	13.2	2.1	1.4	3.4	1.3	10.9	8.3	7.0	2.9	3.0	0.4	3.4	6.9	18.2	22.2	29.4	4.4	8.9	1.9	4.1	1.9	1.7	54.1	5.1	8.2	2.3	1.7	1.2	2.1	1.3	5.5	2.7	1.2	1.2	1.3	6.1	1.4	1.1	12.2	1.1	3.8	1.3	5.3	0.2	2.6	1.3	11.1	1.3	2.5	0.6	2.5	3.4	0.9	1.7	3.8	1.4	2.0	1.6	2.5	2.4	4.7	2.5	1.5	3.8	2.6	1.2	1.3	0.4	6.9	2.2	15.9	1.3	38.9	19.6	57.3	2.6	2.7	38.6	45.0	2.8	0.6	7.2	2.4	8.9	0.3	9.2	7.0	2.6	0.5	3.7	3.8	0.7	3.6	1.0	0.4	12.4	2.0	1.9	1.8	1.7	1.8	1.6	2.0	2.8	1.9	2.2	2.0	2.1	2.9	2.0	0.0	1.1	0.3	2.0	0.0	4.6	0.0	1.2	0.6	8.3	4.6	0.6	2.8	0.6	1.8	2.1	92.9	5.4	0.0	0.0	3.6	92.3	8.6	21.5	2.0	2.4	0.0	0.3	3.3	18.1	17.7	0.0	18.1	0.0	2.0	3.9	7.6	13.2	0.0	0.9	0.5	0.0	3.1	0.0	184.9	22.1	7.2	0.0	0.0	4.0	7.1	3.1	6.6	0.5	2.7	0.3	13.2	2.6	4.9	0.0	0.9	0.0	0.5	13.1	2.0	4.6	1.5	1.2	2.0	0.0	68.4	4.2	1.1	0.2	4.1
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 563.0;Late spermatids: 1154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome		NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	122.7	170.7	101.1	66.9	108.4	66.6	107.9	103.6	134.3	135.9	103.8	133.7	191.2	95.9	82.2	131.5	118.9	77.7	243.9	98.6	104.2	136.7	63.3	151.7	52.7	111.7	107.1	169.7	282.5	94.4	92.0	133.5	110.6	160.4	103.3	56.4	92.5	95.6	232.0	50.9	210.3	89.4	105.8	164.5	115.0	203.8	106.7	26.7	101.3	266.8	47.2	107.7	95.5	115.4	156.2	99.6	32.2	134.3	85.6	189.2	99.2	142.1	170.7	109.9	127.3	35.0	108.5	0.8	161.6	161.7	124.8	228.8	90.3	144.1	102.2	204.9	41.2	90.7	111.8	60.0	148.5	1.1	53.0	109.4	98.5	104.8	26.9	191.1	263.7	0.5	118.7	2.0	198.0	110.7	0.5	1.5	19.1	175.5	188.8	10.1	59.3	130.7	138.7	37.1	1.5	82.5	116.9	17.3	162.4	118.6	75.3	73.8	188.7	111.1	41.4	252.0	97.1	3.0	0.6	2.7	85.4	90.8	117.8	60.6	104.9	121.2	51.5	107.6	25.7	27.3	28.9	35.5	103.6	22.9	33.7	56.1	8.6	86.0	90.7	10.3	5.0	91.1	101.1	108.4	103.6	134.3	98.6	104.2	111.7	107.1	110.6	105.8	106.7	115.4	127.8	51.3	69.6	34.3	33.0	20.5	68.4	141.8	23.9	28.4	62.4	63.0	142.6	42.9	141.6	75.4	20.9	146.4	56.8	237.9	99.7	194.6	563.0	89.4	91.4	137.5	73.0	29.9	14.2	338.3	346.6	84.9	108.6	47.8	104.5	83.5	232.7	31.9	182.3	30.3	21.5	169.7	114.0	181.9	70.2	1154.3	83.3	124.2	64.0	92.8	151.8	172.4	46.4	31.7	56.2	318.5	237.0	85.0	17.4	99.3	418.3	216.4	174.2	50.4	78.9	119.7	104.6	233.2	33.1	34.0	26.3	161.4	42.2	65.0	206.5	94.9
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643421-60658259	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	5.5	0.4	0.3	0.0	0.5	0.0	1.9	0.5	1.2	15.2	1.0	0.0	0.0	0.0	0.4	1.1	0.8	0.5	0.0	0.3	0.3	0.0	0.0	1.5	0.5	0.3	0.4	0.2	0.3	47.8	19.8	0.0	0.4	13.2	0.0	0.0	51.1	0.2	119.4	0.3	0.0	0.0	0.3	0.0	0.4	1.7	0.5	9.7	1.9	46.3	0.2	1.6	0.8	0.4	15.2	3.5	0.6	28.1	17.0	20.6	0.4	4.1	10.6	4.9	4.0	0.0	8.2	0.0	2.2	0.6	2.1	4.4	10.3	6.4	2.1	0.0	17.1	2.0	1.9	6.8	0.0	0.0	0.2	15.6	4.9	2.3	0.7	36.3	0.3	1.6	5.8	0.0	142.2	2.8	0.0	0.5	0.0	0.0	8.9	0.0	71.9	0.0	5.9	16.3	2.5	0.3	5.0	0.3	6.1	0.5	3.3	0.4	13.9	6.7	5.4	7.9	6.5	0.5	0.1	0.0	1.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.2	0.3	0.3	0.3	0.4	0.4	0.3	0.5	0.4	0.8	3.2	1.5	0.0	0.0	0.1	30.7	30.8	0.6	0.0	1.0	0.8	0.9	0.0	33.9	1.8	0.0	0.2	0.0	0.1	1.9	0.0	0.2	1.1	0.1	1.6	0.0	0.0	0.0	0.8	0.4	5.7	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.6	0.0	0.3	0.0	1.9	0.0	0.8	0.0	1.0	0.1	0.2	0.0	1.2	0.0	27.4	0.0	0.1	67.1	0.2	0.0	77.3	5.1	0.0	25.0	0.1	0.1	0.3	0.1	0.1	0.0	18.3
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357074-100422055	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 11.3;intestine: 5.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 13.3;Proximal enterocytes: 43.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.3;midbrain: 8.3;pons: 6.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			CAB079058		Supported				NA	NA				"Cluster 45: Intestine - Brush border"		"Cluster 45: Enterocytes - Digestion"			"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.0	0.0	0.4	0.0	11.3	0.0	0.0	0.0	1.6	0.0	0.7	0.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.5	0.0	0.0	0.4	8.3	0.0	0.0	0.0	0.0	0.3	6.5	0.0	0.3	1.2	0.0	0.0	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.1	1.6	1.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.3	0.0	1.6	0.4	1.3	0.4	8.3	6.5	0.2	1.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.3	0.1	0.1	0.0	0.0	0.4	0.0	3.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.6	1.1	0.0	3.2	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	0.0	0.0	0.0	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660828-107717809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"thyroid gland: 263.7"	"Cell type enhanced"	"Detected in many"		"Club cells: 19.0;Excitatory neurons: 29.3;Inhibitory neurons: 53.9;Ionocytes: 54.9;Prostatic glandular cells: 17.3;Urothelial cells: 19.9"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Group enriched"	"Detected in many"	88	"amygdala: 4.0;basal ganglia: 10.2;cerebral cortex: 11.8;hippocampal formation: 8.8"	"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;hTERT-RPE1: 3.7;LHCN-M2: 2.1"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.8"	HPA042860	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.4	0.1	4.0	0.1	10.2	0.0	0.8	0.0	11.8	1.4	0.0	0.2	0.1	0.5	0.1	0.1	0.3	0.4	0.6	8.8	0.0	6.4	0.1	0.5	0.4	0.0	0.0	0.3	0.3	3.9	0.3	0.3	0.0	3.8	0.2	0.1	0.4	0.2	0.5	0.2	0.1	0.3	0.0	0.1	0.7	0.6	0.0	0.2	263.7	0.1	0.2	1.5	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.0	0.0	1.6	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.4	0.2	0.0	3.7	0.0	0.3	0.0	0.1	2.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.1	1.3	0.3	0.3	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	10.2	0.0	11.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	7.7	2.6	0.2	1.7	0.7	6.5	0.0	6.6	3.2	1.8	0.6	0.0	19.0	0.0	2.1	0.3	0.4	0.4	0.0	0.2	3.9	0.3	0.5	4.9	7.3	0.0	29.3	0.0	0.1	1.5	0.0	1.8	5.1	0.2	1.1	0.2	0.3	1.7	53.9	0.0	54.9	0.6	2.0	2.7	0.9	0.7	7.2	3.7	0.7	1.2	1.0	1.5	1.6	0.1	0.1	1.2	0.0	17.3	0.0	0.1	15.2	1.8	0.0	2.9	1.6	2.0	0.4	0.1	1.4	0.0	1.7	0.2	0.5	19.9
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.0;prostate: 83.0;stomach 1: 83.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046977, HPA054176"	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.8	8.2	0.0	2.5	0.0	1.0	5.3	0.0	0.0	22.4	0.0	132.0	100.8	5.9	2.5	2.0	46.9	18.8	0.0	0.0	0.0	32.1	0.4	14.9	0.1	0.3	0.1	1.6	8.9	0.0	16.1	3.5	0.1	83.0	30.3	0.0	42.6	3.9	0.0	1.1	86.8	2.9	0.0	1.6	83.4	0.7	0.0	0.2	1.9	0.0	0.7	11.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	3.7	22.4	36.0	0.0	3.8	0.5	23.0	71.4	0.6	0.3	14.6	6.1	0.4	38.6	180.2	66.2	0.0	0.3	0.5	546.0	3.9	111.2	2.3	127.4	8.9	6.2	46.7	0.0	0.1	213.4	0.5	2.4	208.5	67.5	2.5	1.1	0.4	0.0	0.5	0.0	0.1	327.8	91.6	0.0	0.0	3.2	1.5	2.5	0.0	0.0	1.6	0.7	0.0	0.0	0.0	184.0	299.3	0.4	0.3	142.0	267.7	61.5	406.7	0.6	0.0	0.8	11.9	0.2	0.2	0.5	0.4	0.7	2.3	5.5	259.6	139.4
SMPX	"Chisel, Csl, DFN6, DFNX4"	ENSG00000091482	"Small muscle protein X-linked"	Q9UHP9	X	21705978-21758116	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"heart muscle: 757.5;skeletal muscle: 1183.4;tongue: 1097.5"	"Cell type enriched"	"Detected in some"	22	"Cardiomyocytes: 807.6"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 7.2;stomach cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"GAMG: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077360			Approved	"Plasma membrane"		NA	NA		62000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"		"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	0.2	0.1	2.6	0.5	2.4	0.1	1.1	3.6	3.8	0.3	0.9	25.6	0.7	0.4	0.0	20.0	0.7	0.5	757.5	1.6	4.1	0.1	1.2	0.5	0.2	1.7	3.3	1.1	0.2	0.0	0.2	0.0	1.5	11.1	3.4	1.7	17.8	0.7	1183.4	0.5	4.1	12.6	1.3	0.1	7.2	0.2	5.3	1.5	0.2	1097.5	0.1	3.2	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	3.6	3.8	1.6	4.1	1.7	3.3	1.5	1.3	5.3	2.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	807.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	16.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	35.6	9.5	0.1	0.3	0.0	0.0	0.3	0.1	2.1	0.1	0.0
SPNS2	SLC62A2	ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498881-4539035	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	17.3	2.6	13.1	5.2	14.0	7.9	14.7	13.1	18.2	14.6	0.1	6.5	12.2	8.6	0.6	51.0	7.8	12.1	10.7	14.1	12.1	28.6	3.8	28.3	4.9	26.4	16.2	1.8	10.0	1.1	2.1	7.9	28.9	5.3	2.1	0.6	16.5	2.0	4.4	24.8	10.8	4.8	13.9	11.4	21.0	1.3	15.5	1.7	8.5	3.9	13.3	6.6	22.6	25.1	9.7	1.2	0.0	0.2	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	8.1	0.5	11.8	0.0	0.1	0.5	0.0	0.7	0.0	0.1	0.2	0.6	0.2	0.0	0.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	4.7	0.0	0.0	0.0	3.8	0.2	17.0	0.1	17.6	0.3	0.8	0.0	0.3	161.7	0.5	5.4	0.2	0.0	76.7	0.0	5.1	2.7	7.5	0.2	0.2	0.7	0.3	0.1	0.3	0.3	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	14.0	13.1	18.2	14.1	12.1	26.4	16.2	28.9	13.9	15.5	25.1	32.7	6.4	10.6	1.6	0.2	1.8	0.4	2.1	0.0	1.2	4.3	3.6	1.2	22.8	16.2	22.0	0.0	1.3	0.2	2.8	1.9	16.7	0.2	0.5	1.0	34.5	0.0	3.2	23.4	3.0	30.5	1.7	26.0	2.8	0.0	0.0	12.5	6.7	1.1	6.7	26.2	12.7	2.0	0.3	1.6	0.2	0.6	1.9	1.8	37.5	0.0	0.4	0.0	3.5	97.8	18.6	0.0	0.4	1.2	11.7	1.9	24.3	16.9	1.1	0.0	1.4	3.1	0.6	0.5	0.6	2.4	1.9	1.6	0.1	1.1	39.8
STRC	DFNB16	ENSG00000242866	Stereocilin	Q7RTU9	15	43599563-43618800	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 9.0;pituitary gland: 4.4;retina: 3.6;testis: 5.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Excitatory neurons: 55.7;Inhibitory neurons: 35.4;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048083	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA048083: AB_2732545"	"unprognostic (8.60e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.99e-4)"	"unprognostic (1.58e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-4)"	0.1	0.6	3.5	0.0	3.8	0.0	0.3	9.0	8.0	0.3	0.3	0.3	0.1	0.1	1.0	0.2	0.4	0.0	0.1	3.8	2.4	0.5	0.6	0.1	0.0	3.8	2.2	0.6	0.2	0.0	4.4	0.0	3.7	1.0	0.0	3.6	0.7	0.0	0.4	0.7	0.4	0.0	1.5	0.3	0.3	5.0	3.2	0.6	1.0	0.0	0.0	0.1	0.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.8	9.0	8.0	3.8	2.4	3.8	2.2	3.7	1.5	3.2	4.8	0.2	0.0	0.0	10.1	0.0	0.6	0.1	0.2	0.0	2.6	0.6	0.9	0.3	0.0	0.2	0.0	6.2	0.3	0.0	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.0	0.0	55.7	0.2	0.1	0.1	0.0	0.3	0.0	2.0	0.4	0.3	0.1	3.3	35.4	0.2	0.0	0.3	0.2	0.5	0.0	0.1	1.8	6.5	0.0	2.3	0.0	13.0	15.4	0.2	1.3	0.4	0.1	0.2	0.7	0.1	0.3	8.7	0.0	0.2	0.1	4.5	0.9	0.0	0.4	0.7	0.2	0.0	0.1	0.0
SYNE4	"C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4"	ENSG00000181392	"Spectrin repeat containing nuclear envelope family member 4"	Q8N205	19	36003307-36008813	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 32.0;Breast myoepithelial cells: 35.9;Cytotrophoblasts: 32.6;Syncytiotrophoblasts: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 32.5;Hep G2: 29.1;MCF7: 34.2;SK-BR-3: 40.1;T-47d: 31.0"	"Region enriched"	"Detected in single"	15	"cerebellum: 6.8"	"Not detected"	"Not detected"			HPA060253	Uncertain					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"			"HPA060253: AB_2684233"	"unprognostic (8.54e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.36e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (8.64e-9)"	"unprognostic (1.25e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.97e-2)"	0.2	0.2	1.2	0.2	1.0	0.2	5.2	6.7	1.5	2.6	2.5	1.9	3.2	0.7	7.7	1.2	3.9	1.6	0.2	0.7	2.9	8.4	12.0	3.1	0.2	3.7	3.0	0.3	5.4	12.1	12.7	1.6	3.6	10.9	1.4	0.2	9.2	4.0	0.3	1.1	1.3	0.2	1.3	0.3	3.4	0.2	2.5	1.7	8.6	0.0	0.3	0.8	1.3	1.2	0.3	0.3	0.2	0.4	0.1	0.2	4.3	0.0	0.0	0.0	0.1	32.5	3.8	0.3	0.4	0.0	0.2	0.0	0.3	0.4	0.0	1.1	0.5	0.1	0.8	29.1	0.5	0.0	0.2	0.2	0.2	1.1	0.0	0.0	0.2	1.6	0.4	0.4	0.0	34.2	0.5	0.1	0.2	0.3	0.2	0.9	0.0	0.4	2.2	1.0	5.0	0.0	0.0	40.1	0.2	0.2	31.0	0.3	0.0	0.3	0.6	0.5	0.2	0.5	0.7	0.6	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	6.7	1.5	0.7	2.9	3.7	3.0	3.6	1.3	2.5	1.2	0.3	6.4	17.5	0.3	0.7	0.5	14.9	19.9	5.2	0.9	32.0	35.9	0.4	24.3	20.2	29.5	4.2	32.6	0.8	5.4	25.4	21.2	0.0	9.1	1.0	0.8	29.8	0.0	0.6	8.6	24.7	0.7	8.2	10.7	1.3	0.5	0.7	12.5	2.6	0.0	0.9	10.6	26.4	0.6	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.9	11.7	16.9	0.0	0.0	23.9	4.5	24.2	17.3	0.4	0.0	0.3	1.6	0.1	0.4	2.1	0.4	33.9	1.2	0.1	8.8	9.2
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease variant, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 16.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Inhibitory neurons: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 34.7"									"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavorable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	3.8	3.3	7.5	1.8	8.1	2.5	2.8	3.6	10.5	2.1	0.0	2.0	2.2	1.4	2.8	1.0	2.3	1.9	3.0	8.3	3.7	4.3	3.7	3.9	1.8	2.9	2.9	1.0	10.6	1.9	2.6	2.1	3.1	2.5	0.9	4.2	16.5	3.5	3.4	1.2	1.6	1.7	1.9	2.0	2.2	1.2	4.4	0.9	3.1	1.7	1.2	1.8	0.9	2.8	3.4	6.7	4.5	9.2	5.1	5.1	3.8	6.2	3.3	4.0	3.5	6.2	2.9	8.6	5.2	4.9	1.9	6.3	7.1	2.0	2.9	9.3	8.0	8.0	9.5	5.5	3.1	5.9	3.2	1.9	2.8	3.5	1.4	2.8	5.1	3.3	9.9	4.8	3.8	6.4	4.1	11.9	4.0	3.2	4.3	20.9	8.5	6.1	2.9	2.3	34.7	8.5	3.8	15.3	2.6	1.6	4.8	5.2	5.4	7.8	8.4	7.9	6.2	3.2	3.0	11.0	3.4	8.5	7.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	7.5	8.1	3.6	10.5	8.3	3.7	2.9	2.9	3.1	1.9	4.4	2.8	4.7	28.9	26.7	15.7	1.9	0.5	3.0	1.4	1.8	19.0	17.8	10.8	6.9	10.0	6.9	5.5	43.8	1.5	5.6	2.4	33.2	5.0	0.2	2.8	10.0	5.4	11.4	6.5	29.6	6.1	1.0	5.8	5.6	4.0	3.8	6.0	10.4	17.3	3.5	26.9	34.0	2.6	6.1	5.1	3.3	1.0	9.0	3.0	1.8	6.5	3.6	13.8	6.2	25.1	9.7	5.0	2.8	6.0	1.7	3.1	1.8	3.9	3.6	25.5	0.0	11.2	3.7	8.8	5.9	1.4	1.4	0.3	2.9	3.4	4.7	1.6
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7101970	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 2.9;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Inhibitory neurons: 2.2;Oligodendrocyte precursor cells: 1.0;Squamous epithelial cells: 5.7;Urothelial cells: 1.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-698: 12.3"									"HPA050857, HPA060073"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA050857: , HPA060073: AB_2684196"						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	0.3	0.0	0.1	0.0	1.3	0.0	0.3	0.1	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.8	0.3	0.4	0.2	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.6	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.4	0.1	0.4	0.2	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.2	3.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	5.7	0.0	0.3	0.0	0.0	0.0	1.1
TECTA	"DFNA12, DFNA8, DFNB21"	ENSG00000109927	"Tectorin alpha"	O75443	11	121101243-121191490	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.2;Cone photoreceptor cells: 4.2;Early spermatids: 5.6;Excitatory neurons: 9.9;Hepatic stellate cells: 8.9;Inhibitory neurons: 7.2;Oligodendrocyte precursor cells: 5.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA018870	Approved				"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018870: AB_1857879"	"unprognostic (1.12e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-6)"	"unprognostic (1.22e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.19e-2)"	0.3	0.5	1.6	0.2	2.1	0.2	0.3	1.0	1.6	0.3	1.5	0.5	0.1	0.3	0.6	0.1	0.3	0.3	1.1	1.3	2.0	0.5	0.4	0.4	0.1	1.5	1.4	0.7	0.3	0.8	1.3	0.2	1.5	0.5	0.1	1.1	0.3	0.5	0.8	0.1	0.2	0.2	0.9	0.3	0.3	0.9	1.6	0.2	0.7	0.4	0.1	0.3	0.2	1.9	0.0	0.0	1.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	1.7	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	1.0	1.6	1.3	2.0	1.5	1.4	1.5	0.9	1.6	1.9	0.5	3.2	0.5	5.2	0.1	0.0	0.1	0.0	0.0	1.8	0.2	0.3	1.9	1.5	0.6	0.0	4.2	0.0	0.2	0.0	0.0	0.2	5.6	0.6	0.3	0.5	0.0	0.0	9.9	0.4	0.1	0.4	0.0	0.3	0.0	0.6	8.9	0.6	0.1	0.0	7.2	0.0	0.0	0.3	0.0	2.7	0.3	0.2	0.0	1.0	0.2	0.9	0.0	5.0	2.8	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.2	0.7	0.0	1.9	0.4	0.9	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838297	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Transport"	"Ion channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.2;Early spermatids: 7.9;Endometrial stromal cells: 5.5;Microglial cells: 5.6;Urothelial cells: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HAP1: 5.2;NTERA-2: 1.9;SuSa: 1.0;U-266/70: 1.3;U-266/84: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.5	1.0	0.1	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.5	0.4	0.6	0.6	0.6	0.6	0.5	0.4	0.7	1.3	0.0	0.0	19.2	0.0	0.3	2.9	0.1	0.6	0.2	0.1	0.1	0.4	0.0	0.0	1.8	0.0	4.0	0.1	0.4	0.0	0.2	7.9	1.4	5.5	1.2	0.0	0.0	1.5	0.6	2.8	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	2.6	0.3	0.1	0.0	5.6	0.6	1.1	0.0	1.5	1.3	0.5	2.2	0.0	0.0	3.1	0.0	3.0	0.0	0.0	0.0	0.3	0.2	1.8	3.1	0.5	0.0	2.6	0.1	0.5	0.0	6.8
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	0.7	6.2	14.2	0.5	14.1	0.0	0.4	14.0	18.0	0.7	10.5	1.0	0.4	0.5	0.7	1.5	0.6	0.2	0.7	14.1	19.3	2.3	0.8	1.0	0.8	19.6	15.7	1.5	0.2	0.1	9.9	0.4	19.2	0.5	0.3	0.7	0.5	1.0	3.6	0.7	0.5	0.4	16.0	0.7	0.3	1.5	18.7	0.5	0.9	1.2	0.8	0.6	0.9	14.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	2.7	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.5	10.7	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.1	1.2	0.0	0.3	0.1	0.1	0.3	2.3	0.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	14.2	14.1	14.0	18.0	14.1	19.3	19.6	15.7	19.2	16.0	18.7	14.9	1.9	0.0	0.0	0.3	0.0	0.8	0.2	0.5	0.0	3.8	0.2	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.4	0.5	0.2	0.0	0.7	0.0	0.0	1.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.4	1.5	0.6	0.3	0.0	1.9	0.1	1.4	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.0	1.1	1.0	2.6	3.2	0.0	0.9	0.1	0.2	0.1	0.0	0.2
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371887-42396091	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.7;stomach 1: 14.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 17.7;Cholangiocytes: 24.3;Ductal cells: 16.1;Endometrial ciliated cells: 17.1;Gastric mucus-secreting cells: 23.4;Ionocytes: 16.2;Muller glia cells: 20.4;Respiratory ciliated cells: 39.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 274.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	0.5	0.3	3.8	0.2	4.0	0.1	8.7	4.0	3.7	6.3	2.0	0.2	1.3	0.7	0.0	0.2	23.7	8.6	0.0	3.4	4.1	2.4	0.5	3.4	0.5	4.9	4.7	0.0	3.0	0.0	1.5	0.2	3.7	0.4	0.1	3.9	9.2	0.4	0.1	0.1	1.1	0.0	3.5	0.4	14.5	0.0	4.7	0.9	2.9	0.0	0.4	1.0	0.0	2.7	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	32.9	0.0	66.2	26.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.0	14.0	0.0	1.5	3.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.8	1.5	0.0	0.0	33.9	1.6	0.0	0.0	3.2	0.3	0.1	0.0	1.7	0.0	0.2	0.7	274.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	1.7	1.8	0.0	0.0	0.3	0.9	0.3	0.0	0.5	0.0	0.8	0.5	3.8	4.0	4.0	3.7	3.4	4.1	4.9	4.7	3.7	3.5	4.7	2.7	0.1	12.8	3.7	2.3	0.4	0.3	2.3	8.1	0.0	0.2	17.7	9.9	0.6	24.3	10.8	7.3	0.0	0.0	0.1	1.4	5.9	16.1	1.4	17.1	0.4	0.2	0.0	2.7	0.0	13.8	0.1	1.3	23.4	5.2	0.0	0.2	0.4	0.0	0.1	0.0	0.0	2.0	16.2	0.0	0.5	0.6	0.3	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.1	11.8	1.4	0.0	0.4	2.4	2.9	0.0	39.8	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.1	2.5	5.0
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019575-115118257	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 376.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.3;Basal prostatic cells: 72.1;Basal respiratory cells: 150.6;Basal squamous epithelial cells: 126.3;Prostatic glandular cells: 69.2;Smooth muscle cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 798.5;hTEC/SVTERT24-B: 634.4;U-138 MG: 526.0;U-251 MG: 484.5;U-87 MG: 711.8;WM-115: 1253.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"	NA	NA	560000000	840000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	61.0	4.7	16.4	170.4	28.5	0.9	41.2	14.0	9.8	43.6	3.0	174.3	16.7	106.8	12.2	23.9	25.5	14.1	32.6	15.6	34.3	82.0	7.7	54.2	39.8	20.3	43.8	5.3	4.8	2.3	7.2	4.0	28.0	39.1	28.3	4.8	19.8	33.3	6.2	25.9	56.5	376.2	15.0	40.8	62.4	4.8	65.4	17.1	13.3	3.2	22.6	96.7	15.9	20.5	25.1	6.0	6.9	1.3	37.5	10.1	0.1	205.7	798.5	425.4	203.6	5.3	55.3	0.0	32.8	291.7	6.9	89.9	0.0	12.0	241.3	0.4	2.2	0.0	4.8	0.0	0.7	0.4	3.9	6.2	1.7	634.4	289.9	42.9	0.1	0.0	0.0	5.2	11.4	0.0	0.1	0.3	65.2	0.9	85.3	0.2	451.9	0.1	373.3	0.1	0.6	5.9	91.4	0.2	19.3	140.9	1.0	1.4	0.1	526.0	88.4	94.2	484.5	14.3	0.4	0.4	711.8	0.6	1253.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.4	28.5	14.0	9.8	15.6	34.3	20.3	43.8	28.0	15.0	65.4	20.5	0.7	12.8	43.5	160.3	0.4	12.1	72.1	150.6	126.3	0.1	9.3	33.3	1.4	0.0	14.8	1.8	0.0	1.1	0.3	0.0	0.0	25.8	15.4	6.7	47.8	11.1	0.0	0.0	7.0	4.5	0.6	19.0	0.0	24.9	2.5	0.5	6.1	0.0	1.2	0.0	0.9	0.0	0.0	0.6	4.7	18.4	3.4	0.9	5.4	1.9	0.1	1.3	0.0	4.0	0.8	3.9	0.0	0.4	0.3	69.2	0.0	0.3	3.5	0.2	0.0	1.3	58.9	0.4	0.2	4.8	4.5	1.0	2.6	0.1	0.1	5.8
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;pancreas: 91.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 177.7;Proximal enterocytes: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 61.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 23.6"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.7	5.1	24.3	4.4	37.8	2.7	4.8	29.9	33.1	5.2	15.1	25.4	22.0	4.7	0.9	20.5	5.1	3.2	10.7	23.5	23.7	19.1	24.3	8.1	2.4	33.1	32.4	6.4	91.4	2.5	6.0	3.3	28.2	8.0	6.9	1.7	11.8	3.4	6.2	15.6	26.0	1.5	20.8	5.0	29.3	9.3	31.9	2.0	5.5	3.1	1.5	7.8	6.9	56.4	10.2	11.4	3.8	17.0	5.2	5.5	30.1	7.0	4.3	7.0	3.9	38.5	12.1	18.6	10.1	3.6	9.2	30.4	7.9	3.9	0.9	11.9	11.1	8.7	17.5	25.5	7.9	13.5	10.8	4.7	7.5	6.2	4.3	4.6	4.5	8.2	16.1	6.4	2.1	61.9	8.9	29.0	13.5	55.5	14.8	26.3	9.1	28.4	15.9	21.0	24.4	8.9	10.8	49.6	13.0	2.9	57.8	21.0	5.0	12.7	6.0	20.1	15.1	5.3	11.0	9.7	9.1	12.1	7.2	0.0	0.8	0.0	0.3	0.8	0.1	0.3	0.3	0.5	0.6	0.3	0.1	0.3	0.0	0.8	0.4	0.6	0.6	0.2	24.3	37.8	29.9	33.1	23.5	23.7	33.1	32.4	28.2	20.8	31.9	56.4	4.6	19.2	5.5	6.2	3.5	1.8	1.3	2.6	2.2	19.3	13.2	9.5	7.6	15.7	2.6	16.5	6.2	5.4	8.4	177.7	7.9	8.0	3.1	7.6	4.1	2.9	9.0	7.4	3.3	45.4	1.3	3.0	15.3	9.6	1.3	8.7	3.9	19.5	3.6	11.8	3.8	46.0	6.1	2.8	1.6	5.3	3.4	5.2	5.4	1.0	2.8	12.4	1.0	2.5	30.4	15.3	39.7	4.5	1.9	3.3	95.9	20.0	2.3	7.3	6.6	3.2	4.5	2.7	4.4	5.8	2.8	1.9	4.5	10.3	36.7	1.7
TRIOBP	"DFNB28, HRIHFB2122, KIAA1662, TAP68, Tara"	ENSG00000100106	"TRIO and F-actin binding protein"	Q9H2D6	22	37697048-37776556	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003747, HPA019769"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA003747: AB_1858328, HPA019769: AB_1858329"	"unprognostic (2.94e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.44e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.67e-2)"	56.3	46.5	15.4	27.3	16.6	25.7	50.8	14.7	14.9	73.1	22.1	70.6	23.9	71.8	12.8	78.5	66.1	27.8	74.6	12.8	13.2	37.2	21.6	51.6	17.4	20.0	17.2	55.7	32.7	31.1	16.9	44.2	16.5	45.3	17.0	4.8	44.3	33.3	24.3	32.0	38.0	31.0	16.6	53.1	53.6	26.1	16.9	16.7	48.2	14.3	12.5	66.5	65.7	17.3	65.9	53.1	33.2	26.4	73.1	118.1	47.5	113.0	111.9	57.7	42.1	11.8	44.8	24.5	30.4	69.6	31.6	52.7	9.2	63.7	18.1	39.6	29.1	6.8	41.6	22.4	75.5	32.1	28.9	47.1	29.8	52.0	24.5	125.3	71.9	20.6	6.4	34.6	45.5	39.3	14.4	23.1	20.2	65.4	63.2	25.1	23.9	17.2	41.0	52.8	16.2	25.4	50.9	46.5	59.7	32.8	25.4	23.0	151.9	87.2	38.6	60.6	27.0	30.4	9.1	15.4	82.7	13.0	104.3	7.7	7.6	12.2	1.8	7.5	0.6	1.3	1.5	1.8	4.1	2.4	1.2	1.8	18.2	1.9	12.5	1.9	2.5	2.0	15.4	16.6	14.7	14.9	12.8	13.2	20.0	17.2	16.5	16.6	16.9	17.3	102.0	19.2	29.7	17.9	10.7	6.2	48.3	18.3	18.8	22.8	40.1	45.1	65.2	62.9	23.3	58.8	2.1	105.7	14.7	63.8	15.6	42.7	30.3	32.6	107.0	91.6	22.9	28.2	4.7	51.6	34.2	65.5	58.1	34.2	6.3	128.1	124.6	17.1	42.7	16.8	4.6	52.1	6.1	56.0	7.5	10.6	113.1	31.2	14.2	27.2	32.0	29.6	8.2	7.5	14.0	62.8	46.9	92.2	9.5	41.9	24.8	15.8	23.9	7.3	52.6	17.7	31.8	49.8	23.4	57.2	6.1	116.0	12.7	22.5	40.6	57.9
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	6.0	8.1	3.4	7.4	3.5	11.1	6.2	10.3	3.7	8.3	5.9	7.7	5.3	8.6	3.5	6.8	8.4	4.9	6.8	3.1	2.6	6.2	6.7	7.0	9.3	1.4	2.2	10.9	8.3	10.3	14.0	6.1	1.9	7.1	5.0	7.5	7.1	5.2	7.6	11.2	8.4	6.2	0.6	8.5	7.1	11.0	2.8	15.8	8.8	7.3	8.7	7.3	7.0	5.0	24.0	27.2	27.7	23.4	12.9	13.8	13.7	10.3	13.6	15.8	15.1	21.2	10.3	32.8	15.9	19.1	30.3	12.2	29.1	14.0	17.7	19.2	28.3	20.2	20.3	11.7	9.4	36.9	14.3	12.6	8.0	25.8	21.7	10.9	20.5	29.2	35.4	59.8	14.8	44.0	45.0	13.5	21.1	14.1	16.6	32.7	16.0	25.2	7.7	26.6	21.6	27.1	26.1	16.6	8.4	22.7	8.5	15.7	22.0	21.1	30.6	28.3	24.2	24.7	30.2	47.8	14.9	18.3	21.3	2.8	0.3	0.2	0.5	0.2	0.9	0.6	0.8	0.4	0.3	0.8	0.6	0.6	1.0	0.5	0.3	1.0	0.7	0.1	3.4	3.5	10.3	3.7	3.1	2.6	1.4	2.2	1.9	0.6	2.8	5.0	12.8	16.0	14.2	30.3	16.4	15.8	4.2	8.2	13.1	15.2	13.7	10.0	10.9	5.7	9.4	14.7	27.1	8.9	15.0	7.9	0.0	7.7	3.6	16.6	20.1	11.1	12.6	12.4	43.7	6.5	5.2	11.1	11.2	24.1	5.7	26.5	8.6	11.0	8.0	21.9	45.5	10.4	8.2	10.4	7.4	5.4	8.7	12.3	8.8	29.0	9.8	6.1	6.2	36.7	42.4	8.3	5.8	8.6	25.3	7.6	6.2	5.2	8.3	9.2	0.0	12.8	12.4	14.8	8.4	18.5	21.3	10.9	17.1	12.1	10.1	7.5
TSPEAR	"C21orf29, DFNB98, MGC11251, TSP-EAR"	ENSG00000175894	"Thrombospondin type laminin G domain and EAR repeats"	Q8WU66	21	44497893-44711572	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 1.0;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Early spermatids: 3.3;Excitatory neurons: 1.1;Oligodendrocytes: 1.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.7;U-2 OS: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"CAB034203, CAB034204, HPA052995"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008"	"unprognostic (8.61e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.86e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.86e-4)"	"unprognostic (2.13e-2)"	"unprognostic (4.80e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	1.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
WBP2	"GRAMD6, WBP-2"	ENSG00000132471	"WW domain binding protein 2"	Q969T9	17	75845699-75856507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 321.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065682, HPA068819"	Approved		Supported	Nucleoplasm,Cytosol		No	No		440000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"		"HPA065682: AB_2685530, HPA068819: AB_2686042"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.76e-1)"	113.2	223.6	239.5	57.1	238.6	82.7	114.1	225.1	340.9	103.2	163.6	109.7	65.2	84.6	44.3	94.7	106.1	62.8	183.1	243.0	242.2	125.7	184.4	118.1	60.9	293.9	256.8	113.9	134.5	100.7	116.0	55.4	286.4	103.5	39.0	129.7	137.7	73.5	250.2	131.3	85.7	52.0	226.4	112.5	123.2	95.4	259.8	49.2	83.8	91.9	51.8	97.8	94.7	256.6	104.6	119.9	43.4	52.5	88.0	87.2	57.9	32.7	102.1	74.3	91.8	59.7	104.2	52.9	81.9	47.0	232.2	61.0	45.2	100.9	66.3	40.1	90.4	97.7	66.4	97.6	182.2	40.8	161.6	96.4	94.6	89.4	120.8	127.0	143.8	82.1	68.2	156.7	60.2	107.3	85.8	85.8	37.3	70.8	78.8	57.8	85.4	101.5	109.7	62.3	72.6	114.8	58.5	99.9	163.1	76.3	134.9	102.1	84.3	75.8	66.1	73.6	52.3	145.4	109.6	38.8	212.5	38.3	54.9	239.9	85.0	288.7	53.8	102.6	59.1	68.9	59.5	54.6	54.8	55.3	55.8	47.5	308.9	57.4	136.4	42.0	77.4	93.2	239.5	238.6	225.1	340.9	243.0	242.2	293.9	256.8	286.4	226.4	259.8	256.6	73.5	83.3	79.0	34.9	62.7	60.9	127.2	85.9	30.1	109.7	75.2	53.3	73.2	55.8	59.9	53.3	75.0	64.9	45.9	65.9	162.4	124.3	264.5	41.5	21.7	63.4	33.6	124.0	23.6	188.6	65.1	43.5	34.1	44.3	67.0	40.0	54.3	61.9	138.4	112.7	23.4	48.9	71.2	65.5	71.2	321.1	59.4	90.2	60.5	23.4	90.8	104.8	52.5	21.1	38.6	126.5	72.6	53.8	35.6	120.2	88.4	100.7	44.8	120.7	26.3	43.8	44.9	45.5	25.7	24.8	80.0	184.7	51.7	62.5	27.1	95.6
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
WHRN	"CIP98, DFNB31, PDZD7B, USH2D"	ENSG00000095397	Whirlin	Q9P202	9	114402080-114505473	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 104.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 49.5;Endometrial stromal cells: 13.9;Glandular and luminal cells: 39.6;Plasma cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 97.9;U-266/70: 67.8;U-266/84: 89.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (6.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.43e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.44e-1)"	5.8	104.7	21.7	2.3	33.5	2.6	5.9	24.0	28.9	17.8	47.2	12.4	3.8	36.4	4.1	5.6	11.5	2.3	8.1	21.7	29.3	7.9	4.8	5.0	2.8	37.2	27.5	20.5	14.1	7.1	36.8	1.8	41.4	13.8	1.2	12.4	8.7	4.0	0.5	9.1	8.9	6.3	24.2	20.7	7.9	50.1	31.5	8.6	10.1	0.2	0.9	6.5	7.2	58.7	2.0	2.0	2.4	11.3	1.1	0.5	5.2	1.0	1.9	1.5	0.9	1.0	0.9	0.0	3.0	1.2	16.2	5.3	0.6	1.3	0.4	31.0	7.1	0.0	23.4	3.1	0.6	0.2	0.6	1.0	4.9	5.3	0.4	6.9	0.1	2.6	9.6	97.9	1.4	14.7	0.2	0.3	4.7	0.1	18.1	1.6	0.0	32.3	3.8	0.6	14.9	1.1	6.8	10.2	29.7	3.2	8.0	0.3	1.6	3.4	2.2	4.3	5.6	67.8	89.6	0.7	2.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	21.7	33.5	24.0	28.9	21.7	29.3	37.2	27.5	41.4	24.2	31.5	58.7	1.1	0.0	0.6	0.0	5.2	0.0	0.0	0.0	0.0	0.0	9.2	10.3	0.0	0.0	1.3	0.0	0.0	2.9	10.2	0.0	0.0	1.7	0.0	49.5	13.9	0.7	0.0	0.0	0.0	2.0	2.0	2.0	0.0	39.6	2.5	4.5	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	14.3	0.0	0.0	1.3	8.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.2	7.8	7.1	0.0	0.0